[
  {
    "id": 80134,
    "drug": {
      "current_status": "MARKETED",
      "id": 32178,
      "drug_code": 9892,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251241,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251240,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251239,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00821373",
      "brand_name": "COTAZYM ECS 20",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69249",
      "number_of_ais": "3",
      "ai_group_no": "0302964026"
    },
    "created_date": "2019-04-01T13:57:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00821373",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2019-05-27T00:00:00-04:00",
    "estimated_end_date": "2019-05-29T00:00:00-04:00",
    "actual_end_date": "2019-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-24T18:30:24-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "COTAZYM ECS 20",
    "en_drug_common_name": "PANCRELIPASE DELAYED-RELEASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM E.C.S.",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE À LIBÉRATION RETARDÉE",
    "en_ingredients": "AMYLASE\r\nPROTEASE\r\nLIPASE",
    "fr_ingredients": "Amylase\r\nProtéase\r\nLipase",
    "drug_strength": "100000UNIT\r\n100000UNIT\r\n25000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80141,
    "drug": {
      "current_status": "MARKETED",
      "id": 32148,
      "drug_code": 9831,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251228,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00799998",
      "brand_name": "STERILE WATER FOR IRRIGATION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69138",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2019-04-01T14:36:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00799998",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2019-04-01T00:00:00-04:00",
    "estimated_end_date": "2019-08-06T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2019-08-07T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION",
    "en_drug_common_name": "Sterile Water for Irrigation",
    "fr_drug_brand_name": "Sterile Water for Irrigation",
    "fr_drug_common_name": "Sterile Water for Irrigation",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "IRRIGATION",
    "drug_route_fr": "Irrigation",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80145,
    "drug": {
      "current_status": "MARKETED",
      "id": 32148,
      "drug_code": 9831,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251228,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00799998",
      "brand_name": "STERILE WATER FOR IRRIGATION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69138",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2019-04-01T14:37:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00799998",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2019-04-01T00:00:00-04:00",
    "estimated_end_date": "2019-08-06T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2019-08-07T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION",
    "en_drug_common_name": "Sterile Water for Irrigation",
    "fr_drug_brand_name": "Sterile Water for Irrigation",
    "fr_drug_common_name": "Sterile Water for Irrigation",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "IRRIGATION",
    "drug_route_fr": "Irrigation",
    "drug_package_quantity": "1000 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80166,
    "drug": {
      "current_status": "DORMANT",
      "id": 8844,
      "drug_code": 61047,
      "updated_date": "2025-05-15T06:55:26-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367317,
          "ingredient": {
            "id": 2526,
            "ingredient_code": 945,
            "en_name": "TICLOPIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ticlopidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237701",
      "brand_name": "TICLOPIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122822001"
    },
    "created_date": "2019-04-01T15:07:00-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02237701",
    "company_name": "AA PHARMA INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2019-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-02T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TICLOPIDINE",
    "en_drug_common_name": "Ticlopidine",
    "fr_drug_brand_name": "Ticlopidine",
    "fr_drug_common_name": "Ticlopidine",
    "en_ingredients": "TICLOPIDINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ticlopidine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80177,
    "drug": {
      "current_status": "MARKETED",
      "id": 28802,
      "drug_code": 90912,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260451,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424444",
      "brand_name": "SANDOZ DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2019-04-01T15:36:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "actual_start_date": "2019-03-05T00:00:00-05:00",
    "actual_end_date": "2023-11-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-11-17T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DUTASTERIDE CAPSULE",
    "en_drug_common_name": "DUTASTERIDE",
    "fr_drug_brand_name": "DUTASTERIDE",
    "fr_drug_common_name": "DUTASTERIDE",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80182,
    "drug": {
      "current_status": "MARKETED",
      "id": 15064,
      "drug_code": 75495,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255387,
          "ingredient": {
            "id": 2948,
            "ingredient_code": 12597,
            "en_name": "GLIMEPIRIDE",
            "fr_name": "Glimépiride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269597",
      "brand_name": "SANDOZ GLIMEPIRIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146247002"
    },
    "created_date": "2019-04-01T15:40:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269597",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2019-08-12T00:00:00-04:00",
    "actual_start_date": "2019-02-25T00:00:00-05:00",
    "actual_end_date": "2019-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-09-10T14:13:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLIMEPIRIDE",
    "en_drug_common_name": "GLIMEPIRIDE",
    "fr_drug_brand_name": "GLIMEPIRIDE",
    "fr_drug_common_name": "GLIMEPIRIDE",
    "en_ingredients": "GLIMEPIRIDE",
    "fr_ingredients": "Glimépiride",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80185,
    "drug": {
      "current_status": "MARKETED",
      "id": 15066,
      "drug_code": 75497,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255388,
          "ingredient": {
            "id": 2948,
            "ingredient_code": 12597,
            "en_name": "GLIMEPIRIDE",
            "fr_name": "Glimépiride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269619",
      "brand_name": "SANDOZ GLIMEPIRIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146247003"
    },
    "created_date": "2019-04-01T15:41:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269619",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2019-08-12T00:00:00-04:00",
    "actual_start_date": "2019-02-25T00:00:00-05:00",
    "actual_end_date": "2019-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-09-10T14:13:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLIMEPIRIDE",
    "en_drug_common_name": "GLIMEPIRIDE",
    "fr_drug_brand_name": "GLIMEPIRIDE",
    "fr_drug_common_name": "GLIMEPIRIDE",
    "en_ingredients": "GLIMEPIRIDE",
    "fr_ingredients": "Glimépiride",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80194,
    "drug": {
      "current_status": "MARKETED",
      "id": 20568,
      "drug_code": 82302,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257276,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257275,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337436",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086002"
    },
    "created_date": "2019-04-01T15:45:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337436",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-06-12T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2020-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-06-22T13:55:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "IRBESARTAN HCT",
    "fr_drug_brand_name": "IRBESARTAN HCT",
    "fr_drug_common_name": "IRBESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80197,
    "drug": {
      "current_status": "MARKETED",
      "id": 20570,
      "drug_code": 82303,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257278,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257277,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337444",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2019-04-01T15:46:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-07-10T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-07-20T13:11:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "IRBESARTAN HCT",
    "fr_drug_brand_name": "IRBESARTAN HCT",
    "fr_drug_common_name": "IRBESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80200,
    "drug": {
      "current_status": "MARKETED",
      "id": 20570,
      "drug_code": 82303,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257278,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257277,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337444",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2019-04-01T15:48:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-07-10T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-07-20T13:11:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "IRBESARTAN HCT",
    "fr_drug_brand_name": "IRBESARTAN HCT",
    "fr_drug_common_name": "IRBESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80205,
    "drug": {
      "current_status": "MARKETED",
      "id": 20058,
      "drug_code": 81400,
      "updated_date": "2025-05-15T02:32:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257059,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02328488",
      "brand_name": "SANDOZ IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2019-04-01T15:49:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328488",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-27T14:19:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80210,
    "drug": {
      "current_status": "MARKETED",
      "id": 20060,
      "drug_code": 81401,
      "updated_date": "2025-05-15T02:32:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257060,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02328496",
      "brand_name": "SANDOZ IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700003"
    },
    "created_date": "2019-04-01T15:51:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328496",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-27T14:19:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80223,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10886,
      "drug_code": 66804,
      "updated_date": "2025-05-15T04:02:34-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8333270,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242965",
      "brand_name": "AVELOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242001"
    },
    "created_date": "2019-04-01T16:01:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242965",
    "company_name": "BAYER INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "discontinuation_date": "2019-07-04T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-07-05T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AVELOX",
    "en_drug_common_name": "Moxifloxacin",
    "fr_drug_brand_name": "Avelox",
    "fr_drug_common_name": "Moxifloxacine",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "Moxifloxacine",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80230,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 55417,
      "drug_code": 95344,
      "updated_date": "2025-05-15T04:25:13-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357379,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02465248",
      "brand_name": "BELBUCA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241011"
    },
    "created_date": "2019-04-01T18:09:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02465248",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AE",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-04-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All stock has been depleted.",
    "fr_supply_disruption_mitigation": "Tout l'inventaire a été épuisé",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-02T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BELBUCA",
    "en_drug_common_name": "Buprenorphine Buccal Soluble Film",
    "fr_drug_brand_name": "Belbuca",
    "fr_drug_common_name": "Pellicule buccale soluble de buprenorphine",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "150MCG",
    "drug_dosage_form": "FILM, SOLUBLE",
    "drug_dosage_form_fr": "Pellicule, soluble",
    "drug_route": "BUCCAL",
    "drug_route_fr": "Buccale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80233,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 55419,
      "drug_code": 95345,
      "updated_date": "2025-05-15T04:25:13-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357380,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02465256",
      "brand_name": "BELBUCA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241005"
    },
    "created_date": "2019-04-01T18:12:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02465256",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AE",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-04-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All stock has been depleted",
    "fr_supply_disruption_mitigation": "Tout l'inventaire a été épuisé",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-02T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BELBUCA",
    "en_drug_common_name": "Buprenorphine Buccal Soluble Film",
    "fr_drug_brand_name": "Belbuca",
    "fr_drug_common_name": "Pellicule buccale soluble de buprenorphine",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "300MCG",
    "drug_dosage_form": "FILM, SOLUBLE",
    "drug_dosage_form_fr": "Pellicule, soluble",
    "drug_route": "BUCCAL",
    "drug_route_fr": "Buccale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80236,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 55421,
      "drug_code": 95346,
      "updated_date": "2025-05-15T04:25:13-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357381,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "450",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02465264",
      "brand_name": "BELBUCA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241012"
    },
    "created_date": "2019-04-01T18:14:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02465264",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AE",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-04-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All stock has been depleted",
    "fr_supply_disruption_mitigation": "Tout l'inventaire a été épuisé",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-02T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BELBUCA",
    "en_drug_common_name": "Buprenorphine Buccal Soluble Film",
    "fr_drug_brand_name": "Belbuca",
    "fr_drug_common_name": "Pellicule buccale soluble de buprenorphine",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "450MCG",
    "drug_dosage_form": "FILM, SOLUBLE",
    "drug_dosage_form_fr": "Pellicule, soluble",
    "drug_route": "BUCCAL",
    "drug_route_fr": "Buccale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80241,
    "drug": {
      "current_status": "MARKETED",
      "id": 19252,
      "drug_code": 80509,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8256732,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256731,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02319624",
      "brand_name": "OLMETEC PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502002"
    },
    "created_date": "2019-04-01T19:09:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319624",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2019-05-10T00:00:00-04:00",
    "estimated_end_date": "2019-11-01T00:00:00-04:00",
    "actual_start_date": "2019-04-18T00:00:00-04:00",
    "actual_end_date": "2019-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-11-01T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Back orders were partially released on October 17th",
    "fr_comments": "Les commandes en souffrance ont été partiellement libérées le 17 octobre",
    "en_drug_brand_name": "OLMETEC PLUS",
    "en_drug_common_name": "Olmesartan medoxomil and hydrochlorothiazide tablets",
    "fr_drug_brand_name": "OLMETEC PLUS",
    "fr_drug_common_name": "comprimés d'olmésartan médoxomil et hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "olmésartan médoxomil hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80246,
    "drug": {
      "current_status": "MARKETED",
      "id": 24464,
      "drug_code": 87092,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258831,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385287",
      "brand_name": "IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2019-04-01T19:53:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385287",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2019-04-05T00:00:00-04:00",
    "estimated_end_date": "2019-07-05T00:00:00-04:00",
    "actual_start_date": "2019-04-09T00:00:00-04:00",
    "actual_end_date": "2019-07-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-07-06T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80249,
    "drug": {
      "current_status": "MARKETED",
      "id": 24468,
      "drug_code": 87094,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258833,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385309",
      "brand_name": "IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700003"
    },
    "created_date": "2019-04-01T19:54:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385309",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2019-04-22T00:00:00-04:00",
    "estimated_end_date": "2019-05-29T00:00:00-04:00",
    "actual_start_date": "2019-04-17T00:00:00-04:00",
    "actual_end_date": "2019-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-31T18:42:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80252,
    "drug": {
      "current_status": "MARKETED",
      "id": 24470,
      "drug_code": 87095,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258835,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258834,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385317",
      "brand_name": "IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086001"
    },
    "created_date": "2019-04-01T19:58:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385317",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2019-04-15T00:00:00-04:00",
    "estimated_end_date": "2019-05-01T00:00:00-04:00",
    "actual_start_date": "2019-04-05T00:00:00-04:00",
    "actual_end_date": "2019-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-06T17:21:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN HCT",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80259,
    "drug": {
      "current_status": "MARKETED",
      "id": 10908,
      "drug_code": 66827,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8254110,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242987",
      "brand_name": "DIAMICRON MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934002"
    },
    "created_date": "2019-04-01T20:36:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242987",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2019-04-12T00:00:00-04:00",
    "actual_start_date": "2019-03-27T00:00:00-04:00",
    "actual_end_date": "2019-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-04T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DIAMICRON MR",
    "en_drug_common_name": "DIAMICRON MR",
    "fr_drug_brand_name": "Diamicron MR",
    "fr_drug_common_name": "Diamicron MR",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80264,
    "drug": {
      "current_status": "MARKETED",
      "id": 29064,
      "drug_code": 91106,
      "updated_date": "2025-05-15T02:34:21-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260544,
          "ingredient": {
            "id": 3160,
            "ingredient_code": 13350,
            "en_name": "FROVATRIPTAN",
            "fr_name": "Frovatriptan (Succinate de frovatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426471",
      "brand_name": "APO-FROVATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150262001"
    },
    "created_date": "2019-04-01T20:37:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426471",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "hc_updated_date": "2020-06-29T18:46:27-04:00",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2019-01-07T00:00:00-05:00",
    "actual_end_date": "2020-06-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-29T18:46:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FROVATRIPTAN",
    "en_drug_common_name": "Frovatriptan",
    "fr_drug_brand_name": "APO-FROVATRIPTAN",
    "fr_drug_common_name": "FROVATRIPTAN",
    "en_ingredients": "FROVATRIPTAN",
    "fr_ingredients": "FROVATRIPTAN",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80271,
    "drug": {
      "current_status": "MARKETED",
      "id": 27382,
      "drug_code": 89622,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259904,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411628",
      "brand_name": "ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2019-04-01T21:04:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411628",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2019-04-22T00:00:00-04:00",
    "estimated_end_date": "2019-05-24T00:00:00-04:00",
    "actual_start_date": "2019-04-16T00:00:00-04:00",
    "actual_end_date": "2019-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-05-25T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "ROSUVASTATIN-5",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80274,
    "drug": {
      "current_status": "MARKETED",
      "id": 27384,
      "drug_code": 89623,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259905,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411636",
      "brand_name": "ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2019-04-01T21:06:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411636",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2019-05-01T00:00:00-04:00",
    "estimated_end_date": "2019-05-24T00:00:00-04:00",
    "actual_start_date": "2019-04-26T00:00:00-04:00",
    "actual_end_date": "2019-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-05-25T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "ROSUVASTATIN-10",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80298,
    "drug": {
      "current_status": "MARKETED",
      "id": 9764,
      "drug_code": 6379,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250885,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00590827",
      "brand_name": "VOLTAREN SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62896",
      "number_of_ais": "1",
      "ai_group_no": "0114417001"
    },
    "created_date": "2019-04-02T13:54:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00590827",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2019-09-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-09-11T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VOLTAREN SR",
    "en_drug_common_name": "VOLTAREN SR 100MG TAB 100'S",
    "fr_drug_brand_name": "VOLTAREN SR",
    "fr_drug_common_name": "VOLTAREN SR 100MG TABS 100'S",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80302,
    "drug": {
      "current_status": "MARKETED",
      "id": 30118,
      "drug_code": 92156,
      "updated_date": "2025-12-03T00:32:44-05:00",
      "company": {
        "id": 7811,
        "created_date": "2018-05-03T02:30:11-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16250,
        "mfr_code": "",
        "name": "RECORDATI RARE DISEASES CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3080 YONGE STREET, SUITE 6060",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M4N 3N1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260980,
          "ingredient": {
            "id": 3896,
            "ingredient_code": 22149,
            "en_name": "PASIREOTIDE",
            "fr_name": "PASIRÉOTIDE (Pasireotide diaspartate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02437279",
      "brand_name": "SIGNIFOR LAR",
      "brand_name_fr": "",
      "descriptor": "KIT INCLUDES 2ML DILUENT IN A PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154790006"
    },
    "created_date": "2019-04-02T14:03:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437279",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "H01CB",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "anticipated_start_date": "2019-04-18T00:00:00-04:00",
    "estimated_end_date": "2019-05-27T00:00:00-04:00",
    "actual_end_date": "2019-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-12T17:30:31-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SIGNIFOR LAR",
    "en_drug_common_name": "SIGNIFOR LAR 60MG",
    "fr_drug_brand_name": "SIGNIFOR LAR",
    "fr_drug_common_name": "SIGNIFOR LAR 60 MG",
    "en_ingredients": "PASIREOTIDE",
    "fr_ingredients": "PASIREOTIDE",
    "drug_strength": "60MG",
    "drug_dosage_form": "KIT\r\nPOWDER FOR SUSPENSION, SUSTAINED-RELEASE",
    "drug_dosage_form_fr": "Trousse\r\nPoudre pour suspension, à libération pro",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "60 MG",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80305,
    "drug": {
      "current_status": "MARKETED",
      "id": 31682,
      "drug_code": 94035,
      "updated_date": "2025-12-03T00:33:05-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8261875,
          "ingredient": {
            "id": 4160,
            "ingredient_code": 22706,
            "en_name": "ALIROCUMAB",
            "fr_name": "Alirocumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02453819",
      "brand_name": "PRALUENT",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0158030001"
    },
    "created_date": "2019-04-02T15:54:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453819",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2019-04-15T00:00:00-04:00",
    "estimated_end_date": "2019-05-06T00:00:00-04:00",
    "actual_end_date": "2019-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-04-18T12:28:31-04:00",
    "status": "resolved",
    "en_comments": "TEMPORARY SHORTAGE OF PRALUENT, 75mg/mL & 150mg/mL (Alirocumab)\r\nWe recognize the difficulties that this situation may cause for patients and health care providers. We apologize for any inconvenience resulting from this.  \r\nPlease note that both strengths (75 mg/mL and 150mg/mL) are not equivalent. For more information, please contact your healthcare professional. All efforts are being made to resolve the situation and any update will be communicated on the www.drugshortagescanada.ca website.",
    "fr_comments": "RUPTURE TEMPORAIRE D’INVENTAIRE DE PRALUENT, 75mg/mL & 150mg/mL (Alirocumab)\r\nNous reconnaissons les difficultés que cette situation peut causer aux patients et aux professionnels de la santé. Nous vous prions de bien vouloir nous excuser  de tout inconvénient pouvant être occasionné.\r\nVeuillez prendre note, que les deux dosages (75mg/mL & 150mg/mL) ne sont pas équivalents. Pour plus d’information, veuillez communiquer avec votre professionnel de la santé. Tous les efforts sont faits pour résoudre cette situation; tout développement vous sera communiqué via le site internet de www.drugshortagescanada.ca.",
    "en_drug_brand_name": "PRALUENT",
    "en_drug_common_name": "Praluent Pen 75mg/mL",
    "fr_drug_brand_name": "PRALUENT PEN 75MG/ML",
    "fr_drug_common_name": "PRALUENT PEN 75MG/ML",
    "en_ingredients": "ALIROCUMAB",
    "fr_ingredients": "Alirocumab",
    "drug_strength": "75MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2 pre-filled pens",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80308,
    "drug": {
      "current_status": "MARKETED",
      "id": 31684,
      "drug_code": 94037,
      "updated_date": "2025-12-03T00:33:05-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8261876,
          "ingredient": {
            "id": 4160,
            "ingredient_code": 22706,
            "en_name": "ALIROCUMAB",
            "fr_name": "Alirocumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02453835",
      "brand_name": "PRALUENT",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0158030002"
    },
    "created_date": "2019-04-02T15:57:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453835",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2019-05-06T00:00:00-04:00",
    "estimated_end_date": "2019-05-13T00:00:00-04:00",
    "actual_end_date": "2019-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-05-10T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "TEMPORARY SHORTAGE OF PRALUENT, 75mg/mL & 150mg/mL (Alirocumab)\r\nWe recognize the difficulties that this situation may cause for patients and health care providers. We apologize for any inconvenience resulting from this.  \r\nPlease note that both strengths (75 mg/mL and 150mg/mL) are not equivalent. For more information, please contact your healthcare professional. All efforts are being made to resolve the situation and any update will be communicated on the www.drugshortagescanada.ca website.",
    "fr_comments": "RUPTURE TEMPORAIRE D’INVENTAIRE DE PRALUENT, 75mg/mL & 150mg/mL (Alirocumab)\r\nNous reconnaissons les difficultés que cette situation peut causer aux patients et aux professionnels de la santé. Nous vous prions de bien vouloir nous excuser  de tout inconvénient pouvant être occasionné.\r\nVeuillez prendre note, que les deux dosages (75mg/mL & 150mg/mL) ne sont pas équivalents. Pour plus d’information, veuillez communiquer avec votre professionnel de la santé. Tous les efforts sont faits pour résoudre cette situation; tout développement vous sera communiqué via le site internet de www.drugshortagescanada.ca.",
    "en_drug_brand_name": "PRALUENT",
    "en_drug_common_name": "PRALUENT PEN 150MG/ML",
    "fr_drug_brand_name": "PRALUENT PEN 150MG/ML",
    "fr_drug_common_name": "PRALUENT PEN 150MG/ML",
    "en_ingredients": "ALIROCUMAB",
    "fr_ingredients": "Alirocumab",
    "drug_strength": "150MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2 pre-filled pens",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80326,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10498,
      "drug_code": 65795,
      "updated_date": "2025-05-15T04:01:39-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8332200,
          "ingredient": {
            "id": 328,
            "ingredient_code": 7219,
            "en_name": "DIPYRIDAMOLE",
            "fr_name": "Dipyridamole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        },
        {
          "id": 8332199,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242119",
      "brand_name": "AGGRENOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215712003"
    },
    "created_date": "2019-04-02T21:04:36-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242119",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-02-24T00:00:00-05:00",
    "anticipated_discontinuation_date": "2019-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Today is the last day for selling",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-02-25T06:00:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "AGGRENOX",
    "en_drug_common_name": "Aggrenox 200/25mg",
    "fr_drug_brand_name": "AGGRENOX",
    "fr_drug_common_name": "Aggrenox 200/25mg",
    "en_ingredients": "ACETYLSALICYLIC ACID\r\nDIPYRIDAMOLE",
    "fr_ingredients": "Acide acétylsalicylique\r\nDipyridamole",
    "drug_strength": "25MG\r\n200MG",
    "drug_dosage_form": "CAPSULE (IMMEDIATE AND EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération immédiate et prolo",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80329,
    "drug": {
      "current_status": "MARKETED",
      "id": 2640,
      "drug_code": 1628,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250286,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250285,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250284,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250283,
          "ingredient": {
            "id": 8,
            "ingredient_code": 1074,
            "en_name": "SODIUM LACTATE",
            "fr_name": "Lactate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00061085",
      "brand_name": "LACTATED RINGER'S INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "42170",
      "number_of_ais": "4",
      "ai_group_no": "0400132001"
    },
    "created_date": "2019-04-03T00:21:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00061085",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2019-04-02T00:00:00-04:00",
    "estimated_end_date": "2019-05-01T00:00:00-04:00",
    "actual_start_date": "2019-04-02T00:00:00-04:00",
    "actual_end_date": "2019-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2019-05-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LACTATED RINGERS INJ USP",
    "en_drug_common_name": "Lactated Ringers Injection",
    "fr_drug_brand_name": "Lactated Ringers Injection",
    "fr_drug_common_name": "Lactated Ringers Injection",
    "en_ingredients": "SODIUM LACTATE\r\nCALCIUM CHLORIDE\r\nPOTASSIUM CHLORIDE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Lactate de sodium\r\nChlorure de calcium\r\nChlorure de potassium\r\nChlorure de sodium",
    "drug_strength": "310MG\r\n20MG\r\n30MG\r\n600MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80332,
    "drug": {
      "current_status": "MARKETED",
      "id": 34,
      "drug_code": 10040,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251278,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060208",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69686",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2019-04-03T00:22:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060208",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2019-04-02T00:00:00-04:00",
    "estimated_end_date": "2019-05-01T00:00:00-04:00",
    "actual_start_date": "2019-04-02T00:00:00-04:00",
    "actual_end_date": "2019-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-02T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP",
    "en_drug_common_name": "0.9% Sodium Chloride Injection",
    "fr_drug_brand_name": "0.9% Sodium Chloride Injection",
    "fr_drug_common_name": "0.9% Sodium Chloride Injection",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "250 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80335,
    "drug": {
      "current_status": "MARKETED",
      "id": 8884,
      "drug_code": 61149,
      "updated_date": "2025-12-03T00:30:40-05:00",
      "company": {
        "id": 272,
        "created_date": "2017-03-09T13:22:39-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12428,
        "mfr_code": "",
        "name": "SANOFI PASTEUR LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "Customer Service/Service à la clientèle: 1-800-268-4171\r\nVaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146"
      },
      "drug_ingredients": [
        {
          "id": 8253543,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02237792",
      "brand_name": "AVAXIM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0165325002"
    },
    "created_date": "2019-04-03T03:46:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237792",
    "company_name": "SANOFI PASTEUR LIMITED",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2019-07-01T00:00:00-04:00",
    "estimated_end_date": "2019-08-01T00:00:00-04:00",
    "actual_start_date": "2019-04-24T00:00:00-04:00",
    "actual_end_date": "2019-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-07-03T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "The shortage has been resolved.",
    "fr_comments": "La pénurie a été résolue.",
    "en_drug_brand_name": "AVAXIM",
    "en_drug_common_name": "Hepatitis A Vaccine Inactivated",
    "fr_drug_brand_name": "AVAXIM®",
    "fr_drug_common_name": "Vaccin inactivé contre l’hépatite A",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Virus inactivé de l’hépatite A (souche GBM)",
    "drug_strength": "160UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1 x 0.5 mL (single dose) syringe",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80347,
    "drug": {
      "current_status": "MARKETED",
      "id": 5888,
      "drug_code": 4114,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 1930,
        "created_date": "2017-03-09T13:26:25-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16088,
        "mfr_code": "",
        "name": "LUPIN PHARMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "550-1111 RUE ST-CHARLES OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LONGUEUIL",
        "postal_code": "J4K 5G4",
        "post_office_box": "",
        "contact_information": "lupin@lsu3pl.ca (Customer service / Service à la clientèle)"
      },
      "drug_ingredients": [
        {
          "id": 8250594,
          "ingredient": {
            "id": 966,
            "ingredient_code": 11447,
            "en_name": "CROMOLYN SODIUM",
            "fr_name": "Cromolyne sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00500895",
      "brand_name": "NALCROM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56686",
      "number_of_ais": "1",
      "ai_group_no": "0108810001"
    },
    "created_date": "2019-04-03T12:29:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00500895",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A07EB",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2019-04-22T00:00:00-04:00",
    "estimated_end_date": "2019-06-30T00:00:00-04:00",
    "actual_end_date": "2019-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-06-26T13:22:27-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "La date de disponibilité est la date de disponibilité estimée au niveau du centre de distribution principal de Sanofi. La date de disponibilité au niveau du centre de distribution du grossiste habituel d’un client peut varier. Les pharmacies sont invitées à communiquer directement avec leur grossiste pour avoir une date de disponibilité pour le produit. Les patients sont invités à communiquer directement avec leur pharmacie pour obtenir plus de détails à propos de la disponibilité du produit.",
    "en_drug_brand_name": "NALCROM",
    "en_drug_common_name": "Nalcrom 100 mg",
    "fr_drug_brand_name": "NALCROM",
    "fr_drug_common_name": "Nalcrom 100 mg",
    "en_ingredients": "CROMOLYN SODIUM",
    "fr_ingredients": "Cromolyne sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80353,
    "drug": {
      "current_status": "MARKETED",
      "id": 2290,
      "drug_code": 15163,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252009,
          "ingredient": {
            "id": 1108,
            "ingredient_code": 2282,
            "en_name": "DANAZOL",
            "fr_name": "Danazol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02018152",
      "brand_name": "CYCLOMEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76844",
      "number_of_ais": "1",
      "ai_group_no": "0110952002"
    },
    "created_date": "2019-04-03T12:47:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02018152",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "G03XA",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "estimated_end_date": "2019-12-02T00:00:00-05:00",
    "actual_start_date": "2019-03-15T00:00:00-04:00",
    "actual_end_date": "2019-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-06-26T13:34:08-04:00",
    "status": "resolved",
    "en_comments": "Delay in manufacturing  June 25, 2019: A small quantity of Cyclomen 100 mg (DIN 02018152) has been secured and is now released. Allocation will be made for pending POs based on ordering history",
    "fr_comments": "Délai de production 25 Juin, 2019 - Une  quantité limitée du produit est maintenant disponible.  Les quantités seront allouées en fonction de l' historique d’achat",
    "en_drug_brand_name": "CYCLOMEN",
    "en_drug_common_name": "Cyclomen 100 mg",
    "fr_drug_brand_name": "CYCLOMEN 100 MG",
    "fr_drug_common_name": "Cyclomen 100 mg",
    "en_ingredients": "DANAZOL",
    "fr_ingredients": "Danazol",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80356,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8820,
      "drug_code": 60957,
      "updated_date": "2025-05-15T03:56:31-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8325280,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237618",
      "brand_name": "ADALAT XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253002"
    },
    "created_date": "2019-04-03T12:51:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237618",
    "company_name": "BAYER INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "actual_start_date": "2019-03-27T00:00:00-04:00",
    "actual_end_date": "2020-12-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-10T17:26:13-05:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Abandonné",
    "en_drug_brand_name": "ADALAT XL - SRT 20MG",
    "en_drug_common_name": "Nifedipine extended-release tablets Bayer Standard",
    "fr_drug_brand_name": "Adalat XL",
    "fr_drug_common_name": "Nifedipine",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28's and 98's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80359,
    "drug": {
      "current_status": "MARKETED",
      "id": 28800,
      "drug_code": 90911,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260450,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424428",
      "brand_name": "ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2019-04-03T13:13:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424428",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2019-04-03T00:00:00-04:00",
    "actual_end_date": "2019-12-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-12-25T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM",
    "fr_drug_brand_name": "ESCITALOPRAM",
    "fr_drug_common_name": "ESCITALOPRAM",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80362,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7746,
      "drug_code": 50798,
      "updated_date": "2025-05-15T03:51:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8316699,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231474",
      "brand_name": "DILTIAZEM-CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2019-04-03T13:15:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231474",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "actual_start_date": "2019-04-03T00:00:00-04:00",
    "actual_end_date": "2019-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-26T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DILTIAZEM - CD",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "DILTIAZEM - CD",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80371,
    "drug": {
      "current_status": "MARKETED",
      "id": 12596,
      "drug_code": 71343,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254616,
          "ingredient": {
            "id": 24,
            "ingredient_code": 8642,
            "en_name": "DOXYCYCLINE",
            "fr_name": "Doxycycline (Hyclate de doxycycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247104",
      "brand_name": "PMS-DOXYCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105569005"
    },
    "created_date": "2019-04-03T13:33:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247104",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "A01AB",
    "atc_description": "STOMATOLOGICAL PREPARATIONS",
    "estimated_end_date": "2019-06-10T00:00:00-04:00",
    "actual_start_date": "2019-04-03T00:00:00-04:00",
    "actual_end_date": "2019-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-28T14:18:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PERIOSTAT",
    "en_drug_common_name": "PERIOSTAT",
    "fr_drug_brand_name": "PERIOSTAT",
    "fr_drug_common_name": "PERIOSTAT",
    "en_ingredients": "DOXYCYCLINE",
    "fr_ingredients": "Doxycycline",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80376,
    "drug": {
      "current_status": "MARKETED",
      "id": 6582,
      "drug_code": 43536,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253104,
          "ingredient": {
            "id": 1932,
            "ingredient_code": 7512,
            "en_name": "DESONIDE",
            "fr_name": "Désonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02229315",
      "brand_name": "PDP-DESONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9877",
      "number_of_ais": "1",
      "ai_group_no": "0106367001"
    },
    "created_date": "2019-04-03T13:47:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229315",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "D07AB",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2019-05-20T00:00:00-04:00",
    "actual_start_date": "2019-04-03T00:00:00-04:00",
    "actual_end_date": "2019-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-06T17:32:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-DESONIDE",
    "en_drug_common_name": "DESONIDE",
    "fr_drug_brand_name": "DESONIDE",
    "fr_drug_common_name": "DESONIDE",
    "en_ingredients": "DESONIDE",
    "fr_ingredients": "Désonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80379,
    "drug": {
      "current_status": "MARKETED",
      "id": 6582,
      "drug_code": 43536,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253104,
          "ingredient": {
            "id": 1932,
            "ingredient_code": 7512,
            "en_name": "DESONIDE",
            "fr_name": "Désonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02229315",
      "brand_name": "PDP-DESONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9877",
      "number_of_ais": "1",
      "ai_group_no": "0106367001"
    },
    "created_date": "2019-04-03T13:59:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229315",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "D07AB",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2019-05-06T00:00:00-04:00",
    "estimated_end_date": "2019-07-26T00:00:00-04:00",
    "actual_start_date": "2019-05-06T00:00:00-04:00",
    "actual_end_date": "2019-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-12T13:20:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-DESONIDE",
    "en_drug_common_name": "DESONIDE",
    "fr_drug_brand_name": "PDP-DESONIDE",
    "fr_drug_common_name": "DESONIDE",
    "en_ingredients": "DESONIDE",
    "fr_ingredients": "Désonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80393,
    "drug": {
      "current_status": "MARKETED",
      "id": 14714,
      "drug_code": 75010,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255283,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.04",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02264633",
      "brand_name": "RETIN-A MICRO",
      "brand_name_fr": "",
      "descriptor": "MICROSPHERES GEL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112395006"
    },
    "created_date": "2019-04-03T14:27:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264633",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-04-10T18:15:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RETIN-A MICRO",
    "en_drug_common_name": "RETIN-A MICRO",
    "fr_drug_brand_name": "RETIN-A MICRO",
    "fr_drug_common_name": "RETIN-A MICRO",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.04%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "50g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80416,
    "drug": {
      "current_status": "MARKETED",
      "id": 14240,
      "drug_code": 74319,
      "updated_date": "2025-12-03T00:31:00-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255136,
          "ingredient": {
            "id": 2430,
            "ingredient_code": 5044,
            "en_name": "ISOTRETINOIN",
            "fr_name": "Isotrétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257955",
      "brand_name": "CLARUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115751001"
    },
    "created_date": "2019-04-03T17:11:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257955",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "D10BA",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE",
    "anticipated_start_date": "2019-04-16T00:00:00-04:00",
    "estimated_end_date": "2019-05-10T00:00:00-04:00",
    "actual_end_date": "2019-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-08T12:04:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLARUS",
    "en_drug_common_name": "Isotretinoin",
    "fr_drug_brand_name": "CLARUS",
    "fr_drug_common_name": "Isotretinoin",
    "en_ingredients": "ISOTRETINOIN",
    "fr_ingredients": "Isotrétinoïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80423,
    "drug": {
      "current_status": "MARKETED",
      "id": 52181,
      "drug_code": 92868,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261353,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261352,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443902",
      "brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
      "brand_name_fr": "MYLAN-EMTRICITABINE/TÉNOFOVIR DISOPROXIL",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251568001"
    },
    "created_date": "2019-04-03T17:17:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443902",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2019-04-10T00:00:00-04:00",
    "estimated_end_date": "2019-05-30T00:00:00-04:00",
    "actual_start_date": "2019-04-10T00:00:00-04:00",
    "actual_end_date": "2019-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-23T11:16:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "en_drug_common_name": "EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "fr_drug_brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "fr_drug_common_name": "EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE\r\nEMTRICITABINE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil\r\nEmtricitabine",
    "drug_strength": "300MG\r\n200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80428,
    "drug": {
      "current_status": "MARKETED",
      "id": 3536,
      "drug_code": 18874,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8252395,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02172712",
      "brand_name": "MYLAN-BECLO AQ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81154",
      "number_of_ais": "1",
      "ai_group_no": "0106320002"
    },
    "created_date": "2019-04-03T17:25:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172712",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "anticipated_start_date": "2019-06-05T00:00:00-04:00",
    "actual_end_date": "2019-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-06-19T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-BECLO AQ",
    "en_drug_common_name": "BECLO AQ",
    "fr_drug_brand_name": "MYLAN-BECLO AQ",
    "fr_drug_common_name": "BECLO AQ",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL\r\nSUSPENSION",
    "drug_dosage_form_fr": "Aérosol à dose mesurée\r\nSuspension",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "22s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80435,
    "drug": {
      "current_status": "MARKETED",
      "id": 16150,
      "drug_code": 76937,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255761,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02283794",
      "brand_name": "MYLAN-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806002"
    },
    "created_date": "2019-04-03T17:55:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02283794",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2019-04-03T00:00:00-04:00",
    "estimated_end_date": "2019-04-05T00:00:00-04:00",
    "actual_end_date": "2019-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-07-04T10:44:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "MYLAN-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80441,
    "drug": {
      "current_status": "MARKETED",
      "id": 25780,
      "drug_code": 88165,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259302,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259301,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396610",
      "brand_name": "FREYA 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2019-04-03T17:59:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396610",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2019-04-03T00:00:00-04:00",
    "actual_end_date": "2019-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-07-03T10:53:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FREYA 28",
    "en_drug_common_name": "FREYA 28",
    "fr_drug_brand_name": "FREYA 28",
    "fr_drug_common_name": "FREYA 28",
    "en_ingredients": "DESOGESTREL\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Désogestrel\r\nÉthinylestradiol",
    "drug_strength": "0.15MG\r\n0.03MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28 BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80452,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8934,
      "drug_code": 61286,
      "updated_date": "2025-05-15T03:56:53-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8325713,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237921",
      "brand_name": "MYLAN-VERAPAMIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113846002"
    },
    "created_date": "2019-04-03T18:08:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237921",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C08DA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2019-08-29T00:00:00-04:00",
    "estimated_end_date": "2019-10-18T00:00:00-04:00",
    "actual_start_date": "2019-07-29T00:00:00-04:00",
    "actual_end_date": "2019-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-10-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VERAPAMIL",
    "en_drug_common_name": "VERAPAMIL",
    "fr_drug_brand_name": "MYLAN-VERAPAMIL",
    "fr_drug_common_name": "VERAPAMIL",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80463,
    "drug": {
      "current_status": "MARKETED",
      "id": 10270,
      "drug_code": 65259,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253890,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241602",
      "brand_name": "LIPIDIL SUPRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895004"
    },
    "created_date": "2019-04-03T18:54:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241602",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2019-05-09T00:00:00-04:00",
    "estimated_end_date": "2019-05-10T00:00:00-04:00",
    "actual_end_date": "2019-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-30T18:54:20-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "LIPIDIL SUPRA",
    "en_drug_common_name": "LIPIDIL SUPRA",
    "fr_drug_brand_name": "LIPIDIL SUPRA",
    "fr_drug_common_name": "LIPIDIL SUPRA",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3x10",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80466,
    "drug": {
      "current_status": "MARKETED",
      "id": 13610,
      "drug_code": 73429,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 448,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 13687,
        "mfr_code": "",
        "name": "TAKEDA PHARMACEUTICALS AMERICA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "500 KENDALL STREET",
        "province": "MASSACHUSETTS",
        "country": "UNITED STATES",
        "city": "CAMBRIDGE",
        "postal_code": "02142",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254918,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02249464",
      "brand_name": "PREVACID FASTAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666002"
    },
    "created_date": "2019-04-03T19:08:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249464",
    "company_name": "TAKEDA PHARMACEUTICALS AMERICA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-01T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PREVACID FASTAB",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "PREVACID FASTAB",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3 x 10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80469,
    "drug": {
      "current_status": "MARKETED",
      "id": 13612,
      "drug_code": 73430,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 448,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 13687,
        "mfr_code": "",
        "name": "TAKEDA PHARMACEUTICALS AMERICA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "500 KENDALL STREET",
        "province": "MASSACHUSETTS",
        "country": "UNITED STATES",
        "city": "CAMBRIDGE",
        "postal_code": "02142",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254919,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02249472",
      "brand_name": "PREVACID FASTAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666001"
    },
    "created_date": "2019-04-03T19:12:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249472",
    "company_name": "TAKEDA PHARMACEUTICALS AMERICA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2019-04-03T00:00:00-04:00",
    "actual_end_date": "2019-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-08T16:14:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PREVACID FASTAB",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "PREVACID FASTAB",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "LANSOPRAZOLE",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3 x 10, 10 x 10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80478,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 686,
      "drug_code": 11481,
      "updated_date": "2025-05-15T03:38:06-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8288209,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8288208,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00870935",
      "brand_name": "SINEMET CR 200/50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72185",
      "number_of_ais": "2",
      "ai_group_no": "0210315004"
    },
    "created_date": "2019-04-03T19:49:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00870935",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA",
    "atc_description": "DOPAMINERGIC AGENTS",
    "discontinuation_date": "2019-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Inventory already depleted",
    "fr_supply_disruption_mitigation": "Inventaire déjà écoulé",
    "en_discontinuation_comments": "Discontinuation due to Supply Chain Challenges",
    "fr_discontinuation_comments": "Discontinuation en raison de problèmes de chaîne d'approvisionnement",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-04-03T19:56:46-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SINEMET CR 200/50",
    "en_drug_common_name": "levodopa and carbidopa controlledrelease tablets",
    "fr_drug_brand_name": "SINEMET CR",
    "fr_drug_common_name": "comprimés de lévodopa et de carbidopa à libération prolongée",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "50MG\r\n200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100TAB",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80483,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1922,
      "drug_code": 14082,
      "updated_date": "2025-05-15T03:40:14-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8292805,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8292804,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02028786",
      "brand_name": "SINEMET CR 100/25",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75589",
      "number_of_ais": "2",
      "ai_group_no": "0210315003"
    },
    "created_date": "2019-04-03T20:01:19-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02028786",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA",
    "atc_description": "DOPAMINERGIC AGENTS",
    "discontinuation_date": "2019-10-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinuation due to Supply Chain Challenges",
    "fr_discontinuation_comments": "Discontinuation en raison de problèmes de chaîne d'approvisionnement",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-11-01T13:38:01-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SINEMET CR 100/25",
    "en_drug_common_name": "levodopa and carbidopa controlled release tablets",
    "fr_drug_brand_name": "SINEMET CR",
    "fr_drug_common_name": "comprimés de lévodopa et de carbidopa à libération prolongée",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100TAB",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80490,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4420,
      "drug_code": 2142,
      "updated_date": "2025-05-15T03:25:04-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8272927,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8272926,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00328219",
      "brand_name": "SINEMET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "47755",
      "number_of_ais": "2",
      "ai_group_no": "0210315001"
    },
    "created_date": "2019-04-03T20:23:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00328219",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA",
    "atc_description": "DOPAMINERGIC AGENTS",
    "hc_updated_date": "2022-07-28T17:02:31-04:00",
    "anticipated_start_date": "2019-11-22T00:00:00-05:00",
    "estimated_end_date": "2022-08-31T00:00:00-04:00",
    "actual_start_date": "2019-11-22T00:00:00-05:00",
    "actual_end_date": "2022-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-28T17:02:34-04:00",
    "status": "resolved",
    "en_comments": "Discontinued / Discontinué",
    "fr_comments": "Discontinued / Discontinué",
    "en_drug_brand_name": "SINEMET 250/25",
    "en_drug_common_name": "levodopa and carbidopa tablets",
    "fr_drug_brand_name": "Sinemet",
    "fr_drug_common_name": "comprimés de levodopa and carbidopa",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80521,
    "drug": {
      "current_status": "MARKETED",
      "id": 11078,
      "drug_code": 67236,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254163,
          "ingredient": {
            "id": 506,
            "ingredient_code": 309,
            "en_name": "IRON",
            "fr_name": "Fer (Complexe fer-dextran)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243333",
      "brand_name": "FERRLECIT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108536035"
    },
    "created_date": "2019-04-04T12:25:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243333",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B03AC",
    "atc_description": "IRON PREPARATIONS",
    "estimated_end_date": "2019-04-12T00:00:00-04:00",
    "actual_start_date": "2019-04-04T00:00:00-04:00",
    "actual_end_date": "2019-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-04-06T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Supply delay",
    "fr_comments": "Retard d'approvisionnement",
    "en_drug_brand_name": "FERRLECIT",
    "en_drug_common_name": "Sodium Ferric Gluconate",
    "fr_drug_brand_name": "Ferrlecit",
    "fr_drug_common_name": "Sodium Ferric Gluconate",
    "en_ingredients": "IRON",
    "fr_ingredients": "Fer",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80526,
    "drug": {
      "current_status": "MARKETED",
      "id": 16318,
      "drug_code": 77111,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 16988,
        "created_date": "2020-11-09T00:00:05-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 18078,
        "mfr_code": "",
        "name": "COVIS PHARMA GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "GRAFENAUWEG 12",
        "province": "ZUG",
        "country": "SWITZERLAND",
        "city": "ZUG",
        "postal_code": "6300",
        "post_office_box": "",
        "contact_information": "Covis Pharma GmbH\r\nGrafenauweg 12\r\nZug, 6300 \r\nSwitzerland"
      },
      "drug_ingredients": [
        {
          "id": 8255821,
          "ingredient": {
            "id": 3346,
            "ingredient_code": 19961,
            "en_name": "CICLESONIDE",
            "fr_name": "Ciclésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02285606",
      "brand_name": "ALVESCO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151669003"
    },
    "created_date": "2019-04-04T15:46:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285606",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2019-04-18T00:00:00-04:00",
    "estimated_end_date": "2019-05-09T00:00:00-04:00",
    "actual_start_date": "2019-04-18T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-05-11T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing capacity constraints",
    "fr_comments": "Manufacturing capacity constraints",
    "en_drug_brand_name": "ALVESCO",
    "en_drug_common_name": "ciclesonide",
    "fr_drug_brand_name": "Alvesco",
    "fr_drug_common_name": "ciclésonide",
    "en_ingredients": "CICLESONIDE",
    "fr_ingredients": "Ciclésonide",
    "drug_strength": "100MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "120 doses",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80530,
    "drug": {
      "current_status": "MARKETED",
      "id": 51713,
      "drug_code": 93840,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261774,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261773,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452006",
      "brand_name": "APO-EMTRICITABINE-TENOFOVIR",
      "brand_name_fr": "APO-EMTRICITABINE-TÉNOFOVIR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251568001"
    },
    "created_date": "2019-04-04T19:27:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452006",
    "company_name": "APOTEX INC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2019-05-30T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-21T15:49:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-EMTRICITABINE-TENOFOVIR",
    "en_drug_common_name": "EMTRICITABINE-TENOFOVIR",
    "fr_drug_brand_name": "APO EMTRICITABINE-TENOFOVIR",
    "fr_drug_common_name": "EMTRICITABINE-TENOFOVIR",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE\r\nEMTRICITABINE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil\r\nEmtricitabine",
    "drug_strength": "300MG\r\n200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80533,
    "drug": {
      "current_status": "DORMANT",
      "id": 22538,
      "drug_code": 85029,
      "updated_date": "2025-05-15T06:55:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368559,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365383",
      "brand_name": "APO-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2019-04-04T19:31:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365383",
    "company_name": "APOTEX INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2019-08-01T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-02T21:08:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE",
    "fr_drug_brand_name": "APO-FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80536,
    "drug": {
      "current_status": "MARKETED",
      "id": 2866,
      "drug_code": 16947,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252177,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02126222",
      "brand_name": "AA-IPRAVENT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79061",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2019-04-04T19:33:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02126222",
    "company_name": "APOTEX INC",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2019-06-28T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-02T15:17:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IPRAVENT SOLUTION - INH 250MCG/ML",
    "en_drug_common_name": "IPRAVENT SOLUTION - INH 250MCG/ML",
    "fr_drug_brand_name": "APO-IPRAVENT SOLUTION - INH 250MCG/ML",
    "fr_drug_common_name": "IPRAVENT SOLUTION - INH 250MCG/ML",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "20 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80539,
    "drug": {
      "current_status": "MARKETED",
      "id": 9050,
      "drug_code": 61677,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253563,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238281",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2019-04-04T19:40:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238281",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-03-27T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2020-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-03-28T01:43:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80542,
    "drug": {
      "current_status": "DORMANT",
      "id": 21384,
      "drug_code": 83782,
      "updated_date": "2025-12-03T02:32:27-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368454,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02352567",
      "brand_name": "APO-MYCOPHENOLATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158002"
    },
    "created_date": "2019-04-04T19:41:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352567",
    "company_name": "APOTEX INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2019-11-01T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-11-05T17:49:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MYCOPHENOLATE",
    "en_drug_common_name": "MYCOPHENOLATE",
    "fr_drug_brand_name": "APO-MYCOPHENOLATE",
    "fr_drug_common_name": "MYCOPHENOLATE",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80545,
    "drug": {
      "current_status": "MARKETED",
      "id": 12534,
      "drug_code": 71247,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254605,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247013",
      "brand_name": "APO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2019-04-04T19:42:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247013",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-04-12T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-15T21:12:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "APO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80570,
    "drug": {
      "current_status": "MARKETED",
      "id": 3148,
      "drug_code": 18025,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252241,
          "ingredient": {
            "id": 1364,
            "ingredient_code": 2474,
            "en_name": "NALOXONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de naloxone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02148706",
      "brand_name": "NALOXONE HCL INJECTION - 0.4MG/ML USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80237",
      "number_of_ais": "1",
      "ai_group_no": "0108981002"
    },
    "created_date": "2019-04-05T13:54:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148706",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2019-07-08T00:00:00-04:00",
    "actual_start_date": "2019-04-05T00:00:00-04:00",
    "actual_end_date": "2019-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-07-08T14:26:20-04:00",
    "status": "resolved",
    "en_comments": "Limited inventory is currently available for this product at Sandoz. To maintain our inventory levels and to avoid unanticipated bulk orders, the product will be placed on protective allocation at 150% of historical monthly volumes until return date.",
    "fr_comments": "Un inventaire limité est actuellement disponible pour ce produit chez Sandoz Canada. Pour maintenir nos stocks et éviter des niveaux élevés de commandes imprévues, le produit sera placé en allocation à 150% des volumes mensuels historiques jusqu'à la date de retour.",
    "en_drug_brand_name": "NALOXONE HCL INJECTION - 0.4MG/ML USP",
    "en_drug_common_name": "NALOXONE HCl Inj",
    "fr_drug_brand_name": "NALOXONE HCl Inj",
    "fr_drug_common_name": "NALOXONE HCl Inj",
    "en_ingredients": "NALOXONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de naloxone",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "1X10ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80573,
    "drug": {
      "current_status": "MARKETED",
      "id": 3146,
      "drug_code": 18024,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252240,
          "ingredient": {
            "id": 1364,
            "ingredient_code": 2474,
            "en_name": "NALOXONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de naloxone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02148714",
      "brand_name": "NALOXONE HCL INJECTION - 1MG/ML USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80236",
      "number_of_ais": "1",
      "ai_group_no": "0108981001"
    },
    "created_date": "2019-04-05T13:55:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148714",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2019-06-17T00:00:00-04:00",
    "actual_start_date": "2019-04-05T00:00:00-04:00",
    "actual_end_date": "2019-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2019-06-28T21:14:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NALOXONE HCL INJECTION - 1MG/ML USP",
    "en_drug_common_name": "NALOXONE HCl Inj",
    "fr_drug_brand_name": "NALOXONE HCl Inj",
    "fr_drug_common_name": "NALOXONE HCl Inj",
    "en_ingredients": "NALOXONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de naloxone",
    "drug_strength": "1MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10X2ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80576,
    "drug": {
      "current_status": "MARKETED",
      "id": 31640,
      "drug_code": 93978,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261852,
          "ingredient": {
            "id": 1364,
            "ingredient_code": 2474,
            "en_name": "NALOXONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de naloxone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02453258",
      "brand_name": "S.O.S. NALOXONE HYDROCHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108981002"
    },
    "created_date": "2019-04-05T13:56:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453258",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2019-05-10T00:00:00-04:00",
    "estimated_end_date": "2019-07-01T00:00:00-04:00",
    "actual_start_date": "2019-05-03T00:00:00-04:00",
    "actual_end_date": "2019-07-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-07-03T16:18:54-04:00",
    "status": "resolved",
    "en_comments": "Limited inventory is currently available for this product at Sandoz. To maintain our inventory levels and to avoid unanticipated bulk orders, the product will be placed on protective allocation at 100% of historical monthly volumes staring April 16th 2019 until return date.",
    "fr_comments": "Un inventaire limité est actuellement disponible pour ce produit chez Sandoz Canada. Pour maintenir nos stocks et éviter des niveaux élevés de commandes imprévues, le produit sera placé en allocation dès le 16 Avril 2019 à 100% des volumes mensuels historiques jusqu'à la date de retour.",
    "en_drug_brand_name": "S.O.S. NALOXONE HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "NALOXONE HCl Inj SOS",
    "fr_drug_brand_name": "NALOXONE HCl Inj SOS",
    "fr_drug_common_name": "NALOXONE HCl Inj SOS",
    "en_ingredients": "NALOXONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de naloxone",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10X1ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80579,
    "drug": {
      "current_status": "MARKETED",
      "id": 25812,
      "drug_code": 88192,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259309,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396912",
      "brand_name": "ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434002"
    },
    "created_date": "2019-04-05T14:09:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396912",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "actual_start_date": "2019-04-05T00:00:00-04:00",
    "actual_end_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "18MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80590,
    "drug": {
      "current_status": "MARKETED",
      "id": 30248,
      "drug_code": 92309,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8261052,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02438690",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732007"
    },
    "created_date": "2019-04-05T15:06:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438690",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2019-11-06T00:00:00-05:00",
    "estimated_end_date": "2020-02-20T00:00:00-05:00",
    "actual_start_date": "2019-11-05T00:00:00-05:00",
    "actual_end_date": "2020-02-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-02-21T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "100MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "30dose",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80599,
    "drug": {
      "current_status": "MARKETED",
      "id": 8802,
      "drug_code": 60885,
      "updated_date": "2025-12-03T00:30:40-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253526,
          "ingredient": {
            "id": 486,
            "ingredient_code": 7746,
            "en_name": "HEPATITIS B SURFACE ANTIGEN",
            "fr_name": "Antigène de surface du virus de l'hépatite b (recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253525,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "360",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02237548",
      "brand_name": "TWINRIX JUNIOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0265323001"
    },
    "created_date": "2019-04-05T17:24:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237548",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2019-05-16T00:00:00-04:00",
    "actual_start_date": "2019-04-02T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-11T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TWINRIX JUNIOR",
    "en_drug_common_name": "Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine",
    "fr_drug_brand_name": "TWINRIX JUNIOR",
    "fr_drug_common_name": "Vaccin bivalent contre l’hépatite A (inactivé) et l’hépatite B (recombinant)",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED\r\nHEPATITIS B SURFACE ANTIGEN",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactive; Antigène de surface de l’hépatite B",
    "drug_strength": "360UNIT\r\n10MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80604,
    "drug": {
      "current_status": "MARKETED",
      "id": 7382,
      "drug_code": 49817,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253293,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230640",
      "brand_name": "TOBRAMYCIN INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230001"
    },
    "created_date": "2019-04-05T17:32:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230640",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "anticipated_start_date": "2019-04-08T00:00:00-04:00",
    "estimated_end_date": "2019-05-06T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-11T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TOBRAMYCIN INJECTION",
    "en_drug_common_name": "Tobramycin for Injection",
    "fr_drug_brand_name": "Tobramycine pour injection",
    "fr_drug_common_name": "Tobramycine pour injection",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "40MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "30 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80607,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13710,
      "drug_code": 7357,
      "updated_date": "2025-05-15T03:31:06-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8281961,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00590819",
      "brand_name": "LOPRESOR INJ 1.0MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65250",
      "number_of_ais": "1",
      "ai_group_no": "0111923004"
    },
    "created_date": "2019-04-05T17:35:02-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00590819",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2019-09-05T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "fr_supply_disruption_mitigation": "STOCK DISPONIBLE - EXPIRATION 31.01.2020",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-09-06T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LOPRESOR INJ 1.0MG/ML",
    "en_drug_common_name": "LOPRESOR 5MG/5ML 1X5 AMPS",
    "fr_drug_brand_name": "LOPRESOR INJ 1.0MG/ML",
    "fr_drug_common_name": "LOPRESOR 5MG/5ML 1X5 AMPS",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 X 5",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80614,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4868,
      "drug_code": 2738,
      "updated_date": "2025-05-15T03:25:26-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8273775,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00397423",
      "brand_name": "LOPRESOR 50MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51124",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2019-04-05T19:11:26-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00397423",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2018-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-05T19:12:34-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LOPRESOR 50MG",
    "en_drug_common_name": "LOPRESOR 50MG TABS 100'S",
    "fr_drug_brand_name": "LOPRESOR 50MG",
    "fr_drug_common_name": "LOPRESOR 50MG TABS 500'S",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500'S",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80623,
    "drug": {
      "current_status": "MARKETED",
      "id": 15820,
      "drug_code": 76560,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255666,
          "ingredient": {
            "id": 1124,
            "ingredient_code": 1832,
            "en_name": "MUPIROCIN",
            "fr_name": "Mupirocine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279983",
      "brand_name": "TARO-MUPIROCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117081001"
    },
    "created_date": "2019-04-05T20:54:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279983",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D06AX",
    "atc_description": "ANTIBIOTICS FOR TOPICAL USE",
    "estimated_end_date": "2019-05-17T00:00:00-04:00",
    "actual_start_date": "2019-03-29T00:00:00-04:00",
    "actual_end_date": "2019-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-29T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-MUPIROCIN",
    "en_drug_common_name": "TARO-MUPIROCIN",
    "fr_drug_brand_name": "TARO-MUPIROCIN",
    "fr_drug_common_name": "TARO-MUPIROCIN",
    "en_ingredients": "MUPIROCIN",
    "fr_ingredients": "Mupirocine",
    "drug_strength": "2%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80632,
    "drug": {
      "current_status": "MARKETED",
      "id": 26866,
      "drug_code": 89150,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259682,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02406829",
      "brand_name": "TARO-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2019-04-05T20:58:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02406829",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2021-05-28T00:00:00-04:00",
    "actual_start_date": "2019-04-26T00:00:00-04:00",
    "actual_end_date": "2021-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-06-16T20:04:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-IRBESARTAN",
    "en_drug_common_name": "RAN-IRBESARTAN",
    "fr_drug_brand_name": "RAN-IRBESARTAN",
    "fr_drug_common_name": "RAN-IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80635,
    "drug": {
      "current_status": "MARKETED",
      "id": 16216,
      "drug_code": 77001,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255787,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284448",
      "brand_name": "TARO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2019-04-05T20:59:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284448",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-08-30T00:00:00-04:00",
    "actual_start_date": "2019-04-02T00:00:00-04:00",
    "actual_end_date": "2019-08-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-23T21:35:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-PRAVASTATIN",
    "en_drug_common_name": "RAN-PRAVASTATIN",
    "fr_drug_brand_name": "RAN-PRAVASTATIN",
    "fr_drug_common_name": "RAN-PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80638,
    "drug": {
      "current_status": "MARKETED",
      "id": 20086,
      "drug_code": 81485,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257081,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02329166",
      "brand_name": "TARO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2019-04-05T21:00:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329166",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-07-31T00:00:00-04:00",
    "actual_start_date": "2019-04-02T00:00:00-04:00",
    "actual_end_date": "2019-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-SIMVASTATIN",
    "en_drug_common_name": "RAN-SIMVASTATIN",
    "fr_drug_brand_name": "RAN-SIMVASTATIN",
    "fr_drug_common_name": "RAN-SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80641,
    "drug": {
      "current_status": "MARKETED",
      "id": 22416,
      "drug_code": 84812,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258043,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02363100",
      "brand_name": "TARO-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2019-04-05T21:01:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02363100",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2021-02-28T00:00:00-05:00",
    "actual_start_date": "2019-04-05T00:00:00-04:00",
    "actual_end_date": "2021-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-01T21:25:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VALSARTAN",
    "en_drug_common_name": "RAN-VALSARTAN",
    "fr_drug_brand_name": "RAN-VALSARTAN",
    "fr_drug_common_name": "RAN-VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80717,
    "drug": {
      "current_status": "MARKETED",
      "id": 9030,
      "drug_code": 61606,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253559,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238213",
      "brand_name": "PROPECIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110002"
    },
    "created_date": "2019-04-08T12:26:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238213",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D11AX",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "anticipated_start_date": "2019-04-10T00:00:00-04:00",
    "estimated_end_date": "2019-04-17T00:00:00-04:00",
    "actual_end_date": "2019-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-09T15:11:20-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PROPECIA",
    "en_drug_common_name": "Finasteride tablets",
    "fr_drug_brand_name": "PROPECIA",
    "fr_drug_common_name": "Comprimés de finastéride",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80755,
    "drug": {
      "current_status": "MARKETED",
      "id": 52269,
      "drug_code": 94973,
      "updated_date": "2025-12-03T00:33:20-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262382,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461986",
      "brand_name": "SANDOZ LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843001"
    },
    "created_date": "2019-04-08T18:32:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461986",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2019-08-26T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2019-08-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-09-25T12:44:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80771,
    "drug": {
      "current_status": "MARKETED",
      "id": 8334,
      "drug_code": 5707,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250813,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00614254",
      "brand_name": "TOBREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61339",
      "number_of_ais": "1",
      "ai_group_no": "0110230005"
    },
    "created_date": "2019-04-08T20:25:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00614254",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01AA",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2019-04-25T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2019-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-26T11:25:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TOBREX",
    "en_drug_common_name": "TOBREX OINT 3.5G",
    "fr_drug_brand_name": "TOBREX",
    "fr_drug_common_name": "TOBREX OINT 3.5G",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "3MG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3.5G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80787,
    "drug": {
      "current_status": "MARKETED",
      "id": 59283,
      "drug_code": 96770,
      "updated_date": "2025-05-15T02:36:29-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263301,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476916",
      "brand_name": "MINT-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2019-04-08T20:50:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02476916",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2019-06-30T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2019-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-16T00:15:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-CANDESARTAN",
    "en_drug_common_name": "Candesartan",
    "fr_drug_brand_name": "Mint- Candesartan",
    "fr_drug_common_name": "Candesartan",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80792,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25358,
      "drug_code": 87825,
      "updated_date": "2025-05-15T04:20:33-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352007,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8352006,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392992",
      "brand_name": "MINT-IRBESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086001"
    },
    "created_date": "2019-04-08T20:54:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392992",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "hc_updated_date": "2021-08-11T13:09:56-04:00",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2020-07-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-08-11T13:09:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-IRBESARTAN/HCTZ",
    "en_drug_common_name": "Irbesartan HCTZ",
    "fr_drug_brand_name": "Mint-Irbesartan HCTZ",
    "fr_drug_common_name": "Irbesartan/Hyrdochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n150.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80797,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25362,
      "drug_code": 87827,
      "updated_date": "2025-05-15T04:20:33-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352011,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8352010,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393026",
      "brand_name": "MINT-IRBESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2019-04-08T20:56:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393026",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "hc_updated_date": "2021-08-11T13:10:29-04:00",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2020-07-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-08-11T13:10:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-IRBESARTAN/HCTZ",
    "en_drug_common_name": "Irbesartan HCTZ",
    "fr_drug_brand_name": "Mint-Irbesartan HCTZ",
    "fr_drug_common_name": "Irbesartan/Hyrdochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25.0MG\r\n300.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80800,
    "drug": {
      "current_status": "MARKETED",
      "id": 28654,
      "drug_code": 90772,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260397,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422999",
      "brand_name": "MINT-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2019-04-08T20:58:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422999",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2021-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-07-12T16:15:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-IRBESARTAN",
    "en_drug_common_name": "Irbesartan",
    "fr_drug_brand_name": "Mint-Irbesartan",
    "fr_drug_common_name": "Irbesartan",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80803,
    "drug": {
      "current_status": "MARKETED",
      "id": 28656,
      "drug_code": 90773,
      "updated_date": "2025-05-15T02:34:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260398,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423006",
      "brand_name": "MINT-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700003"
    },
    "created_date": "2019-04-08T21:00:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423006",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2021-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-07-12T16:16:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-IRBESARTAN",
    "en_drug_common_name": "Irbesartan",
    "fr_drug_brand_name": "Mint-Irbesartan",
    "fr_drug_common_name": "Irbesartan",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80808,
    "drug": {
      "current_status": "MARKETED",
      "id": 25004,
      "drug_code": 87516,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259044,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259043,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389665",
      "brand_name": "MINT-LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2019-04-08T21:03:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389665",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2020-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-13T15:05:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-LOSARTAN/HCTZ",
    "en_drug_common_name": "losartan/HCTZ",
    "fr_drug_brand_name": "Mint-losartan HCTZ",
    "fr_drug_common_name": "losartan/hctz",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80811,
    "drug": {
      "current_status": "MARKETED",
      "id": 25006,
      "drug_code": 87517,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259046,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259045,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389673",
      "brand_name": "MINT-LOSARTAN/HCTZ DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2019-04-08T21:05:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389673",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2020-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-13T15:05:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-LOSARTAN/HCTZ DS",
    "en_drug_common_name": "losartan/HCTZ",
    "fr_drug_brand_name": "Mint- Losartan/HCTZ",
    "fr_drug_common_name": "losartan/hctz",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25.0MG\r\n100.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80814,
    "drug": {
      "current_status": "MARKETED",
      "id": 28032,
      "drug_code": 90206,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260195,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417448",
      "brand_name": "MINT-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2019-04-08T21:06:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417448",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2019-07-31T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2019-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-19T14:21:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-PANTOPRAZOLE",
    "en_drug_common_name": "Pantoprazole",
    "fr_drug_brand_name": "Mint-Pantprazole",
    "fr_drug_common_name": "Pantoprazole",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "Pantoprazole",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80819,
    "drug": {
      "current_status": "MARKETED",
      "id": 22442,
      "drug_code": 84844,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8258047,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.7",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02363445",
      "brand_name": "OZURDEX",
      "brand_name_fr": "",
      "descriptor": "IMPLANT IN SINGLE-USE APPLICATOR. PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106303011"
    },
    "created_date": "2019-04-08T21:12:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02363445",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2019-04-15T00:00:00-04:00",
    "estimated_end_date": "2019-04-30T00:00:00-04:00",
    "actual_end_date": "2019-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-27T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Rebuilding in country  inventory levels following prior supply disruption. Resupply in late April will be sufficient quantity  to meet ongoing  customer & patient demand.",
    "fr_comments": "Rebuilding in country  inventory levels following prior supply disruption. Resupply in late April will be sufficient quantity  to meet ongoing  customer & patient demand.",
    "en_drug_brand_name": "OZURDEX",
    "en_drug_common_name": "dexamethasone intravitreal implant",
    "fr_drug_brand_name": "OZURDEX",
    "fr_drug_common_name": "dexamethasone intravitreal implant",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "0.7MG",
    "drug_dosage_form": "IMPLANT",
    "drug_dosage_form_fr": "Implant",
    "drug_route": "INTRAVITREAL",
    "drug_route_fr": "Intravitreuse",
    "drug_package_quantity": "1 implant",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80849,
    "drug": {
      "current_status": "MARKETED",
      "id": 10850,
      "drug_code": 66737,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254096,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242905",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2019-04-09T13:12:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242905",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2019-04-19T00:00:00-04:00",
    "estimated_end_date": "2019-07-12T00:00:00-04:00",
    "actual_end_date": "2019-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-26T20:06:46-04:00",
    "status": "resolved",
    "en_comments": "Sandoz is an alternate supplier of Midazolam Injection, and have been informed of our impending supply interruptions",
    "fr_comments": "Sandoz étant un autre fournisseur de Midazolam injectable, nous l’avons informé de nos situations imminentes d’interruption d’approvisionnement",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam Injection",
    "fr_drug_brand_name": "Midazolam injectable",
    "fr_drug_common_name": "Midazolam injectable",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80860,
    "drug": {
      "current_status": "MARKETED",
      "id": 18208,
      "drug_code": 79473,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256390,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309130",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169002"
    },
    "created_date": "2019-04-09T15:40:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309130",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2019-05-07T00:00:00-04:00",
    "actual_start_date": "2019-04-04T00:00:00-04:00",
    "actual_end_date": "2019-05-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-07T12:38:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80863,
    "drug": {
      "current_status": "DORMANT",
      "id": 24932,
      "drug_code": 87446,
      "updated_date": "2025-12-03T02:32:31-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368812,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388936",
      "brand_name": "CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2019-04-09T16:08:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388936",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2019-05-16T00:00:00-04:00",
    "actual_start_date": "2019-04-09T00:00:00-04:00",
    "actual_end_date": "2019-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-16T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80866,
    "drug": {
      "current_status": "MARKETED",
      "id": 24934,
      "drug_code": 87447,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259018,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388944",
      "brand_name": "TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2019-04-09T16:10:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388944",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2019-04-09T00:00:00-04:00",
    "estimated_end_date": "2019-05-27T00:00:00-04:00",
    "actual_start_date": "2019-04-15T00:00:00-04:00",
    "actual_end_date": "2019-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80875,
    "drug": {
      "current_status": "MARKETED",
      "id": 25014,
      "drug_code": 87522,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259052,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389746",
      "brand_name": "PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2019-04-09T17:02:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389746",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2019-04-12T00:00:00-04:00",
    "estimated_end_date": "2019-07-12T00:00:00-04:00",
    "actual_start_date": "2019-04-10T00:00:00-04:00",
    "actual_end_date": "2019-07-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-06T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80880,
    "drug": {
      "current_status": "MARKETED",
      "id": 19080,
      "drug_code": 80342,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256681,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317907",
      "brand_name": "QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2019-04-09T17:12:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317907",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2019-04-23T00:00:00-04:00",
    "estimated_end_date": "2019-05-17T00:00:00-04:00",
    "actual_start_date": "2019-04-23T00:00:00-04:00",
    "actual_end_date": "2019-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-21T12:37:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80923,
    "drug": {
      "current_status": "MARKETED",
      "id": 22336,
      "drug_code": 84736,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257991,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362341",
      "brand_name": "ACETAMINOPHEN CAPLETS 325 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009001"
    },
    "created_date": "2019-04-10T12:17:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362341",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2019-04-12T00:00:00-04:00",
    "actual_start_date": "2019-04-09T00:00:00-04:00",
    "actual_end_date": "2019-04-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-12T05:00:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAMINOPHEN CAPLETS 325 MG",
    "en_drug_common_name": "ACETAMINOPHEN CAPLETS 325 MG",
    "fr_drug_brand_name": "ACETAMINOPHEN CAPLETS 325 MG",
    "fr_drug_common_name": "ACETAMINOPHEN CAPLETS 325 MG",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80926,
    "drug": {
      "current_status": "MARKETED",
      "id": 53517,
      "drug_code": 95540,
      "updated_date": "2025-05-15T02:35:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262665,
          "ingredient": {
            "id": 3520,
            "ingredient_code": 20430,
            "en_name": "DESVENLAFAXINE",
            "fr_name": "Desvenlafaxine (Succinate de desvenlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466996",
      "brand_name": "APO-DESVENLAFAXINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152509002"
    },
    "created_date": "2019-04-10T12:18:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466996",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2019-05-13T00:00:00-04:00",
    "actual_start_date": "2019-04-09T00:00:00-04:00",
    "actual_end_date": "2019-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-14T05:00:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESVENLAFAXINE",
    "en_drug_common_name": "DESVENLAFAXINE",
    "fr_drug_brand_name": "APO-DESVENLAFAXINE",
    "fr_drug_common_name": "DESVENLAFAXINE",
    "en_ingredients": "DESVENLAFAXINE",
    "fr_ingredients": "DESVENLAFAXINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80931,
    "drug": {
      "current_status": "MARKETED",
      "id": 26328,
      "drug_code": 88684,
      "updated_date": "2025-12-03T00:32:13-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259490,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259489,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259488,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.215",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259487,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259486,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259485,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02401967",
      "brand_name": "TRI-CIRA LO 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "6",
      "ai_group_no": "0636783003"
    },
    "created_date": "2019-04-10T12:22:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02401967",
    "company_name": "APOTEX INC",
    "atc_number": "G03AB",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "actual_start_date": "2019-04-09T00:00:00-04:00",
    "actual_end_date": "2019-08-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-26T14:13:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRICIRA LO",
    "en_drug_common_name": "TRICIRA LO",
    "fr_drug_brand_name": "TRICIRA LO",
    "fr_drug_common_name": "TRICIRA LO",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nETHINYL ESTRADIOL\r\nETHINYL ESTRADIOL\r\nNORGESTIMATE\r\nNORGESTIMATE\r\nNORGESTIMATE",
    "fr_ingredients": "Éthinylestradiol\r\nÉthinylestradiol\r\nÉthinylestradiol\r\nNorgestimate\r\nNorgestimate\r\nNorgestimate",
    "drug_strength": "0.025MG\r\n0.025MG\r\n0.025MG\r\n0.180MG\r\n0.215MG\r\n0.250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80934,
    "drug": {
      "current_status": "MARKETED",
      "id": 50624,
      "drug_code": 92810,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261321,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443414",
      "brand_name": "SANDOZ OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496002"
    },
    "created_date": "2019-04-10T12:58:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443414",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2020-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-24T14:42:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN",
    "fr_drug_brand_name": "OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80937,
    "drug": {
      "current_status": "MARKETED",
      "id": 50624,
      "drug_code": 92810,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261321,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443414",
      "brand_name": "SANDOZ OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496002"
    },
    "created_date": "2019-04-10T13:00:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443414",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2020-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-24T14:42:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN",
    "fr_drug_brand_name": "OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80944,
    "drug": {
      "current_status": "MARKETED",
      "id": 50626,
      "drug_code": 92811,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261322,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443422",
      "brand_name": "SANDOZ OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2019-04-10T13:02:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443422",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2020-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-24T14:43:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN",
    "fr_drug_brand_name": "OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80979,
    "drug": {
      "current_status": "MARKETED",
      "id": 21792,
      "drug_code": 84185,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257781,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257780,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356724",
      "brand_name": "SANDOZ VALSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "320MG/12.5MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240204004"
    },
    "created_date": "2019-04-10T13:23:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356724",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2019-04-22T00:00:00-04:00",
    "actual_start_date": "2018-11-05T00:00:00-05:00",
    "actual_end_date": "2019-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-05-07T14:51:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALSARTAN HCT",
    "en_drug_common_name": "VALSARTAN HCT",
    "fr_drug_brand_name": "VALSARTAN HCT",
    "fr_drug_common_name": "VALSARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nVALSARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nValsartan",
    "drug_strength": "12.5MG\r\n320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "2X15bl",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 80984,
    "drug": {
      "current_status": "MARKETED",
      "id": 24156,
      "drug_code": 86783,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258695,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02381966",
      "brand_name": "VORICONAZOLE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE VIAL. 10MG/ML AFTER RECONSTITUTION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242002"
    },
    "created_date": "2019-04-10T13:33:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381966",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2019-07-19T00:00:00-04:00",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2019-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-07-24T14:08:45-04:00",
    "status": "resolved",
    "en_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "fr_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "en_drug_brand_name": "VORICONAZOLE FOR INJECTION",
    "en_drug_common_name": "VORICONAZOLE",
    "fr_drug_brand_name": "VORICONAZOLE",
    "fr_drug_common_name": "VORICONAZOLE",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81021,
    "drug": {
      "current_status": "MARKETED",
      "id": 31394,
      "drug_code": 93683,
      "updated_date": "2025-05-15T02:35:12-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261676,
          "ingredient": {
            "id": 2704,
            "ingredient_code": 11893,
            "en_name": "ABACAVIR",
            "fr_name": "Abacavir (Sulfate d'abacavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261675,
          "ingredient": {
            "id": 1582,
            "ingredient_code": 122,
            "en_name": "LAMIVUDINE",
            "fr_name": "Lamivudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02450682",
      "brand_name": "MYLAN-ABACAVIR/LAMIVUDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251241001"
    },
    "created_date": "2019-04-10T18:07:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450682",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2019-06-07T00:00:00-04:00",
    "estimated_end_date": "2019-06-15T00:00:00-04:00",
    "actual_end_date": "2019-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2019-05-28T15:13:12-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-ABACAVIR/LAMIVUDINE",
    "en_drug_common_name": "ABACAVIR/LAMIVUDINE",
    "fr_drug_brand_name": "MYLAN-ABACAVIR/LAMIVUDINE",
    "fr_drug_common_name": "ABACAVIR/LAMIVUDINE",
    "en_ingredients": "ABACAVIR\r\nLAMIVUDINE",
    "fr_ingredients": "Lamivudine",
    "drug_strength": "600MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81031,
    "drug": {
      "current_status": "MARKETED",
      "id": 50674,
      "drug_code": 94597,
      "updated_date": "2025-05-15T02:35:40-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262189,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458926",
      "brand_name": "MYLAN-DIVALPROEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996004"
    },
    "created_date": "2019-04-10T18:10:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458926",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2019-05-08T00:00:00-04:00",
    "estimated_end_date": "2019-05-15T00:00:00-04:00",
    "actual_end_date": "2019-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-30T18:52:11-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-DIVALPROEX",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "MYLAN-DIVALPROEX",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "125MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81052,
    "drug": {
      "current_status": "MARKETED",
      "id": 12682,
      "drug_code": 71480,
      "updated_date": "2025-12-03T00:30:53-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254640,
          "ingredient": {
            "id": 3034,
            "ingredient_code": 12077,
            "en_name": "PIMECROLIMUS",
            "fr_name": "Pimécrolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02247238",
      "brand_name": "ELIDEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149001001"
    },
    "created_date": "2019-04-10T18:24:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247238",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "D11AH",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2019-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-04-29T17:18:50-04:00",
    "status": "resolved",
    "en_comments": "Recovered",
    "fr_comments": "Resolu",
    "en_drug_brand_name": "ELIDEL",
    "en_drug_common_name": "ELIDEL",
    "fr_drug_brand_name": "ELIDEL",
    "fr_drug_common_name": "ELIDEL",
    "en_ingredients": "PIMECROLIMUS",
    "fr_ingredients": "Pimécrolimus",
    "drug_strength": "1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "30g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81068,
    "drug": {
      "current_status": "MARKETED",
      "id": 4164,
      "drug_code": 20018,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8252595,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02210347",
      "brand_name": "MYLAN-VERAPAMIL SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82317",
      "number_of_ais": "1",
      "ai_group_no": "0113846001"
    },
    "created_date": "2019-04-10T18:29:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02210347",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C08DA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2019-05-01T00:00:00-04:00",
    "estimated_end_date": "2019-07-26T00:00:00-04:00",
    "actual_start_date": "2019-04-16T00:00:00-04:00",
    "actual_end_date": "2019-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-07-30T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VERAPAMIL SR",
    "en_drug_common_name": "VERAPAMIL SR",
    "fr_drug_brand_name": "MYLAN-VERAPAMIL SR",
    "fr_drug_common_name": "VERAPAMIL SR",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "120MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81079,
    "drug": {
      "current_status": "DORMANT",
      "id": 30582,
      "drug_code": 9264,
      "updated_date": "2025-05-15T06:55:22-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366537,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00742554",
      "brand_name": "ISOPTIN SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68215",
      "number_of_ais": "1",
      "ai_group_no": "0113846003"
    },
    "created_date": "2019-04-10T18:39:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00742554",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C08DA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2019-06-28T00:00:00-04:00",
    "actual_start_date": "2019-04-10T00:00:00-04:00",
    "actual_end_date": "2019-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-06-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ISOPTIN SR",
    "en_drug_common_name": "ISOPTIN SR",
    "fr_drug_brand_name": "ISOPTIN SR",
    "fr_drug_common_name": "ISOPTIN SR",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "240MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81121,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6368,
      "drug_code": 43282,
      "updated_date": "2025-05-15T03:49:51-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8312887,
          "ingredient": {
            "id": 1514,
            "ingredient_code": 2007,
            "en_name": "BROMAZEPAM",
            "fr_name": "Bromazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02220520",
      "brand_name": "BROMAZEPAM-3 - TAB 3MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9613",
      "number_of_ais": "1",
      "ai_group_no": "0114488003"
    },
    "created_date": "2019-04-10T19:12:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02220520",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BROMAZEPAM-3 - TAB 3MG",
    "en_drug_common_name": "BROMAZEPAM-3 TAB 3MG",
    "fr_drug_brand_name": "BROMAZAPAM-3 TAB 3MG",
    "fr_drug_common_name": "BROMAZAPAM-3 TAB 3MG",
    "en_ingredients": "BROMAZEPAM",
    "fr_ingredients": "Bromazépam",
    "drug_strength": "3MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81124,
    "drug": {
      "current_status": "MARKETED",
      "id": 31526,
      "drug_code": 93850,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261783,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452243",
      "brand_name": "MAR-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2019-04-10T19:13:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452243",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2019-04-08T00:00:00-04:00",
    "estimated_end_date": "2019-07-05T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2019-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-27T18:37:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-TADALAFIL",
    "en_drug_common_name": "Tadalafil",
    "fr_drug_brand_name": "MAR-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81127,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18414,
      "drug_code": 79685,
      "updated_date": "2025-05-15T04:13:49-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345562,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02311267",
      "brand_name": "PRO-DEXAMETHASONE - 4",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106303003"
    },
    "created_date": "2019-04-10T19:14:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02311267",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-DEXAMETHASONE - 4",
    "en_drug_common_name": "PRO-DEXAMETHASONE - 4",
    "fr_drug_brand_name": "PRO-DEXAMETHASONE - 4",
    "fr_drug_common_name": "PRO-DEXAMETHASONE - 4",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81130,
    "drug": {
      "current_status": "DORMANT",
      "id": 25190,
      "drug_code": 87682,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368831,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391473",
      "brand_name": "MAR-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2019-04-10T19:16:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391473",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2019-04-10T00:00:00-04:00",
    "actual_start_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:04-04:00",
    "status": "active_confirmed",
    "en_comments": "Demand is low, not ordered in recent months",
    "en_drug_brand_name": "MAR-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "MAR-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 TABLET",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81132,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19822,
      "drug_code": 81157,
      "updated_date": "2025-05-15T04:14:41-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8347035,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326221",
      "brand_name": "METHYLPHENIDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548003"
    },
    "created_date": "2019-04-10T19:16:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02326221",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "METHYLPHENIDATE",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "METHYLPHENIDATE",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81136,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19824,
      "drug_code": 81158,
      "updated_date": "2025-05-15T04:14:41-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8347036,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326248",
      "brand_name": "METHYLPHENIDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548001"
    },
    "created_date": "2019-04-10T19:18:34-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02326248",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "METHYLPHENIDATE",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "METHYLPHENIDATE",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81139,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19826,
      "drug_code": 81159,
      "updated_date": "2025-05-15T04:14:41-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8347037,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326256",
      "brand_name": "METHYLPHENIDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548002"
    },
    "created_date": "2019-04-10T19:19:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02326256",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "METHYLPHENIDATE",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "METHYLPHENIDATE",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81142,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3720,
      "drug_code": 19207,
      "updated_date": "2025-05-15T03:45:25-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8302699,
          "ingredient": {
            "id": 1184,
            "ingredient_code": 11182,
            "en_name": "MINOCYCLINE",
            "fr_name": "Minocycline (Chlorhydrate de minocycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02153394",
      "brand_name": "MINOCYCLINE-50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81498",
      "number_of_ais": "1",
      "ai_group_no": "0131309001"
    },
    "created_date": "2019-04-10T19:21:10-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02153394",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MINOCYCLINE-50",
    "en_drug_common_name": "MINOCYCLINE-50",
    "fr_drug_brand_name": "MINOCYCLINE-50",
    "fr_drug_common_name": "MINOCYCLINE-50",
    "en_ingredients": "MINOCYCLINE",
    "fr_ingredients": "MINOCYCLINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81145,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3718,
      "drug_code": 19204,
      "updated_date": "2025-05-15T03:45:25-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8302696,
          "ingredient": {
            "id": 1184,
            "ingredient_code": 11182,
            "en_name": "MINOCYCLINE",
            "fr_name": "Minocycline (Chlorhydrate de minocycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02154366",
      "brand_name": "MINOCYCLINE-100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81495",
      "number_of_ais": "1",
      "ai_group_no": "0131309002"
    },
    "created_date": "2019-04-10T19:22:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02154366",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MINOCYCLINE-100",
    "en_drug_common_name": "MINOCYCLINE-100",
    "fr_drug_brand_name": "MINOCYCLINE-100",
    "fr_drug_common_name": "MINOCYCLINE-100",
    "en_ingredients": "MINOCYCLINE",
    "fr_ingredients": "MINOCYCLINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81148,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27848,
      "drug_code": 90049,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353946,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8353945,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415895",
      "brand_name": "RAMIPRIL-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251649003"
    },
    "created_date": "2019-04-10T19:23:54-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02415895",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAMIPRIL-HCTZ",
    "en_drug_common_name": "RAMIPRIL-HCTZ",
    "fr_drug_brand_name": "RAMIPRIL-HCTZ",
    "fr_drug_common_name": "RAMIPRIL-HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nRAMIPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nRamipril",
    "drug_strength": "12.5MG\r\n10.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81151,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27850,
      "drug_code": 90050,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353948,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8353947,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415909",
      "brand_name": "RAMIPRIL-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251649005"
    },
    "created_date": "2019-04-10T19:24:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02415909",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "discontinuation_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAMIPRIL-HCTZ",
    "en_drug_common_name": "RAMIPRIL-HCTZ",
    "fr_drug_brand_name": "RAMIPRIL-HCTZ",
    "fr_drug_common_name": "RAMIPRIL-HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nRAMIPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nRamipril",
    "drug_strength": "25.0MG\r\n10.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81154,
    "drug": {
      "current_status": "MARKETED",
      "id": 55854,
      "drug_code": 95481,
      "updated_date": "2025-05-15T02:35:57-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262628,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466457",
      "brand_name": "BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555004"
    },
    "created_date": "2019-04-10T19:39:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466457",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2019-11-14T00:00:00-05:00",
    "actual_start_date": "2019-04-10T00:00:00-04:00",
    "actual_end_date": "2019-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-11-13T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BETAHISTINE",
    "en_drug_common_name": "BETAHISTINE",
    "fr_drug_brand_name": "Bêta-histine",
    "fr_drug_common_name": "Bêta-histine",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "24MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81157,
    "drug": {
      "current_status": "MARKETED",
      "id": 29502,
      "drug_code": 91526,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260701,
          "ingredient": {
            "id": 2880,
            "ingredient_code": 12110,
            "en_name": "LINEZOLID",
            "fr_name": "Linézolide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02430827",
      "brand_name": "LINEZOLID INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143501003"
    },
    "created_date": "2019-04-10T20:07:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02430827",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01XX",
    "atc_description": "OTHER ANTIBACTERIALS",
    "anticipated_start_date": "2019-04-11T00:00:00-04:00",
    "estimated_end_date": "2019-06-28T00:00:00-04:00",
    "actual_end_date": "2019-07-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-05T13:58:23-04:00",
    "status": "resolved",
    "en_comments": "Replenishment inventories of our Linezolid Injection 2 mg/mL\r\nfreeflex® Bag 300 mL will be available at all distribution centres effective July 4, 2019",
    "fr_comments": "Cette présentation du produit est disponible auprès de tous nos centres de distribution le 4 juillet 2019.",
    "en_drug_brand_name": "LINEZOLID INJECTION",
    "en_drug_common_name": "Linezolid Injection",
    "fr_drug_brand_name": "Linezolide pour injection",
    "fr_drug_common_name": "Linezolide pour injection",
    "en_ingredients": "LINEZOLID",
    "fr_ingredients": "Linézolide",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "300mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81160,
    "drug": {
      "current_status": "MARKETED",
      "id": 7356,
      "drug_code": 49664,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 592,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 11211,
        "mfr_code": "",
        "name": "VALEO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16667 HYMUS BLVD.",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4R9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253285,
          "ingredient": {
            "id": 2352,
            "ingredient_code": 2958,
            "en_name": "TETRACAINE",
            "fr_name": "Tétracaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02230575",
      "brand_name": "AMETOP GEL 4%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108851002"
    },
    "created_date": "2019-04-10T20:50:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230575",
    "company_name": "SMITH & NEPHEW INC",
    "atc_number": "D04AB",
    "atc_description": "ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.",
    "anticipated_start_date": "2019-01-25T00:00:00-05:00",
    "estimated_end_date": "2019-02-21T00:00:00-05:00",
    "actual_start_date": "2019-02-01T00:00:00-05:00",
    "actual_end_date": "2019-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-04-10T20:53:24-04:00",
    "status": "resolved",
    "en_comments": "Shortage due to some changes to the artwork for some of the other markets that are manufactured with the Canada code.",
    "fr_comments": "Pénurie en raison de certaines modifications apportées à l'étiquetage de d'autres marchés fabriqués avec le lot du Canada.",
    "en_drug_brand_name": "AMETOP GEL 4%",
    "en_drug_common_name": "Tetracaine Hydrochloride Gel",
    "fr_drug_brand_name": "Gel AMETOP 4%",
    "fr_drug_common_name": "Gel de chlorhydrate de tétracaïne",
    "en_ingredients": "TETRACAINE",
    "fr_ingredients": "Tétracaïne",
    "drug_strength": "40MG",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "1.5g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81198,
    "drug": {
      "current_status": "MARKETED",
      "id": 2566,
      "drug_code": 16162,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252090,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8252089,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01976184",
      "brand_name": "SENSORCAINE WITH EPINEPHRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77948",
      "number_of_ais": "2",
      "ai_group_no": "0204884001"
    },
    "created_date": "2019-04-11T12:55:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976184",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2019-04-19T00:00:00-04:00",
    "estimated_end_date": "2019-06-04T00:00:00-04:00",
    "actual_end_date": "2019-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-06-27T11:58:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SENSORCAINE WITH EPINEPHRINE",
    "en_drug_common_name": "Sensorcaine® 0.25% w/epi1:200M, 10x20mL SU Vial",
    "fr_drug_brand_name": "SENSORCAINE AVEC EPINEPHRINE",
    "fr_drug_common_name": "Sensorcaine® 0.25% avec epi1:200M, 10x20mL SU Fiole",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne\r\nÉpinéphrine",
    "drug_strength": "2.5MG\r\n5MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81262,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18302,
      "drug_code": 79587,
      "updated_date": "2025-05-15T04:13:47-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345501,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310228",
      "brand_name": "PRO-FENO-SUPER - 100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895002"
    },
    "created_date": "2019-04-11T15:49:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310228",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2019-06-04T00:00:00-04:00",
    "actual_end_date": "2019-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-06-26T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Has been discontinued\r\nEst maintenant discontinué",
    "fr_comments": "Looking for an alternate source of supply\r\nRecheche d'une source d'approvisionnement alternative",
    "en_drug_brand_name": "PRO-FENO-SUPER - 100",
    "en_drug_common_name": "FENOFIBRATE",
    "fr_drug_brand_name": "PRO-FENO-SUPER - 100",
    "fr_drug_common_name": "PRO-FENO-SUPER - 100",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81265,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18398,
      "drug_code": 79662,
      "updated_date": "2025-05-15T04:13:49-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345553,
          "ingredient": {
            "id": 1106,
            "ingredient_code": 6506,
            "en_name": "HYDROXYCHLOROQUINE SULFATE",
            "fr_name": "Sulfate d'hydroxychloroquine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02311011",
      "brand_name": "PRO-HYDROXYQUINE - 200",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107403001"
    },
    "created_date": "2019-04-11T15:54:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02311011",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "P01BA",
    "atc_description": "ANTIMALARIALS",
    "anticipated_start_date": "2019-06-04T00:00:00-04:00",
    "actual_start_date": "2019-05-22T00:00:00-04:00",
    "actual_end_date": "2019-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-06-26T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Has been discontinued\r\nEst maintenant discontinué",
    "fr_comments": "Has been discontinued\r\nEst maintenant discontinué",
    "en_drug_brand_name": "PRO-HYDROXYQUINE - 200",
    "en_drug_common_name": "PRO-HYDROXYQUINE - 200",
    "fr_drug_brand_name": "PRO-HYDROXYQUINE - 200",
    "fr_drug_common_name": "PRO-HYDROXYQUINE - 200",
    "en_ingredients": "HYDROXYCHLOROQUINE SULFATE",
    "fr_ingredients": "Sulfate d'hydroxychloroquine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81298,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16266,
      "drug_code": 77059,
      "updated_date": "2025-05-15T04:11:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8343145,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285061",
      "brand_name": "TEVA-LISINOPRIL (TYPE P)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550003"
    },
    "created_date": "2019-04-11T16:38:54-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02285061",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:39:23-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-LISINOPRIL (TYPE P)",
    "en_drug_common_name": "LISINOPRIL (TYPE P)",
    "fr_drug_brand_name": "TEVA-LISINOPRIL (TYPE P)",
    "fr_drug_common_name": "LISINOPRIL (TYPE P)",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81301,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17678,
      "drug_code": 78745,
      "updated_date": "2025-12-03T01:25:24-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344752,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8344751,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302144",
      "brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE P)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0222417001"
    },
    "created_date": "2019-04-11T16:40:01-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02302144",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "discontinuation_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:40:14-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE P)",
    "en_drug_common_name": "LISINOPRIL/HCTZ (TYPE P)",
    "fr_drug_brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE P)",
    "fr_drug_common_name": "LISINOPRIL/HCTZ (TYPE P)",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLISINOPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nLisinopril",
    "drug_strength": "12.5MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81304,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10880,
      "drug_code": 66779,
      "updated_date": "2025-05-15T04:02:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8333255,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242940",
      "brand_name": "TEVA-RANITIDINE SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150005"
    },
    "created_date": "2019-04-11T16:41:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242940",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:41:40-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-RANITIDINE SOLUTION",
    "en_drug_common_name": "RANITIDINE SOL",
    "fr_drug_brand_name": "TEVA-RANITIDINE SOLUTION",
    "fr_drug_common_name": "RANITIDINE SOL",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "15MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "300ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81307,
    "drug": {
      "current_status": "MARKETED",
      "id": 10672,
      "drug_code": 66291,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254045,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242540",
      "brand_name": "TEVA-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863006"
    },
    "created_date": "2019-04-11T16:42:20-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242540",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "discontinuation_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:42:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "TEVA - DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "240MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81310,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9578,
      "drug_code": 6320,
      "updated_date": "2025-05-15T03:29:44-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8280184,
          "ingredient": {
            "id": 102,
            "ingredient_code": 2609,
            "en_name": "IBUPROFEN",
            "fr_name": "Ibuprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00629324",
      "brand_name": "NOVO-PROFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62794",
      "number_of_ais": "1",
      "ai_group_no": "0108883004"
    },
    "created_date": "2019-04-11T16:43:27-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00629324",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:43:46-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NOVO-PROFEN",
    "en_drug_common_name": "IBUPROFEN",
    "fr_drug_brand_name": "NOVO-PROFEN",
    "fr_drug_common_name": "IBUPROFEN",
    "en_ingredients": "IBUPROFEN",
    "fr_ingredients": "Ibuprofène",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81313,
    "drug": {
      "current_status": "MARKETED",
      "id": 13310,
      "drug_code": 72911,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254830,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248556",
      "brand_name": "TEVA-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131003"
    },
    "created_date": "2019-04-11T16:44:16-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248556",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:44:30-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "TEVA-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81316,
    "drug": {
      "current_status": "MARKETED",
      "id": 5228,
      "drug_code": 3344,
      "updated_date": "2025-12-03T00:30:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250503,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00452130",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "53941",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2019-04-11T16:45:20-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00452130",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "discontinuation_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:46:12-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "AMOXICILLIN SUS",
    "fr_drug_brand_name": "TEVA- AMOXICILLIN SUS",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "75ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81321,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2376,
      "drug_code": 15559,
      "updated_date": "2025-05-15T03:41:44-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8295215,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02036347",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77254",
      "number_of_ais": "1",
      "ai_group_no": "0131314009"
    },
    "created_date": "2019-04-11T16:47:01-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02036347",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "discontinuation_date": "2018-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:47:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "NOVAMOXIN",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "125MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81330,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2400,
      "drug_code": 15608,
      "updated_date": "2025-05-15T03:41:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8295317,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00872520",
      "brand_name": "HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77313",
      "number_of_ais": "1",
      "ai_group_no": "0106344003"
    },
    "created_date": "2019-04-11T16:50:33-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00872520",
    "company_name": "TEVA CANADA LIMITED",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:51:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION",
    "en_drug_common_name": "HYDROCORTISONE SODIUM SUCCINATE",
    "fr_drug_brand_name": "HYDROCORTISONE SODIUM SUCCINATE INJ",
    "fr_drug_common_name": "HYDROCORTISONE SODIUM SUCCINATE",
    "fr_ingredients": "HYDROCORTISONE",
    "drug_dosage_form_fr": "INJ",
    "drug_route_fr": "N/A",
    "drug_package_quantity": "10",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81337,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2398,
      "drug_code": 15607,
      "updated_date": "2025-05-15T03:41:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8295316,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00872539",
      "brand_name": "HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77312",
      "number_of_ais": "1",
      "ai_group_no": "0106344004"
    },
    "created_date": "2019-04-11T16:51:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00872539",
    "company_name": "TEVA CANADA LIMITED",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:52:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION",
    "en_drug_common_name": "HYDROCORTISONE SODIUM SUCCINATE",
    "fr_drug_brand_name": "HYDROCORTISONE SODIUM SUCCINATE INJ",
    "fr_drug_common_name": "HYDROCORTISONE SODIUM SUCCINATE",
    "fr_ingredients": "HYDROCORTISONE SODIUM SUCCINATE",
    "drug_dosage_form_fr": "INJ",
    "drug_route_fr": "N/A",
    "drug_package_quantity": "10",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81344,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2396,
      "drug_code": 15606,
      "updated_date": "2025-05-15T03:41:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8295315,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00878618",
      "brand_name": "HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77311",
      "number_of_ais": "1",
      "ai_group_no": "0106344011"
    },
    "created_date": "2019-04-11T16:52:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00878618",
    "company_name": "TEVA CANADA LIMITED",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:53:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION",
    "en_drug_common_name": "HYDROCORTISONE SODIUM SUCCINATE",
    "fr_drug_brand_name": "HYDROCORTISONE SODIUM SUCCINATE INJ",
    "fr_drug_common_name": "HYDROCORTISONE SODIUM SUCCINATE",
    "fr_ingredients": "HYDROCORTISONE SODIUM SUCCINATE",
    "drug_dosage_form_fr": "INJ",
    "drug_route_fr": "N/A",
    "drug_package_quantity": "10",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81347,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2394,
      "drug_code": 15605,
      "updated_date": "2025-05-15T03:41:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8295314,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00878626",
      "brand_name": "HYDROCORTISONE SODIUM SUCCINATE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77310",
      "number_of_ais": "1",
      "ai_group_no": "0106344010"
    },
    "created_date": "2019-04-11T16:53:42-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00878626",
    "company_name": "TEVA CANADA LIMITED",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:54:01-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HYDROCORTISONE SODIUM SUCCINATE INJECTION",
    "en_drug_common_name": "HYDROCORTISONE SODIUM SUCCINATE",
    "fr_drug_brand_name": "HYDROCORTISONE SODIUM SUCCINATE INJ",
    "fr_drug_common_name": "HYDROCORTISONE SODIUM SUCCINATE",
    "fr_ingredients": "HYDROCORTISONE SODIUM SUCCINATE",
    "drug_dosage_form_fr": "INJ",
    "drug_route_fr": "N/A",
    "drug_package_quantity": "1",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81350,
    "drug": {
      "current_status": "MARKETED",
      "id": 1772,
      "drug_code": 13848,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251815,
          "ingredient": {
            "id": 40,
            "ingredient_code": 2037,
            "en_name": "NAPROXEN SODIUM",
            "fr_name": "Naproxène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "550",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02026600",
      "brand_name": "TEVA-NAPROXEN SODIUM DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75311",
      "number_of_ais": "1",
      "ai_group_no": "0113934002"
    },
    "created_date": "2019-04-11T16:55:00-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02026600",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:55:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-NAPROXEN SODIUM DS",
    "en_drug_common_name": "NAPROXEN SODIUM",
    "fr_drug_brand_name": "TEVA-NAPROXEN SODIUM",
    "fr_drug_common_name": "NAPROXEN SODIUM",
    "en_ingredients": "NAPROXEN SODIUM",
    "fr_ingredients": "Naproxène sodique",
    "drug_strength": "550MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81353,
    "drug": {
      "current_status": "MARKETED",
      "id": 10110,
      "drug_code": 6479,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250903,
          "ingredient": {
            "id": 582,
            "ingredient_code": 8231,
            "en_name": "BUTALBITAL",
            "fr_name": "Butalbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250902,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "330",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250901,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250900,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00608203",
      "brand_name": "TEVA-TECNAL C 1/4",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63205",
      "number_of_ais": "4",
      "ai_group_no": "0401238002"
    },
    "created_date": "2019-04-11T16:56:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00608203",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:56:31-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-TECNAL C 1/4",
    "en_drug_common_name": "TECNAL C 1/4",
    "fr_drug_brand_name": "TEVA- TECNAL C 1/4",
    "fr_drug_common_name": "TECNAL C 1/4",
    "en_ingredients": "ACETYLSALICYLIC ACID\r\nBUTALBITAL\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acide acétylsalicylique\r\nButalbital\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "330MG\r\n50MG\r\n15MG\r\n40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81362,
    "drug": {
      "current_status": "MARKETED",
      "id": 11234,
      "drug_code": 6763,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250941,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250940,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250939,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00653233",
      "brand_name": "TEVA-LENOLTEC NO. 1",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": true,
      "accession_number": "63992",
      "number_of_ais": "3",
      "ai_group_no": "0311391002"
    },
    "created_date": "2019-04-11T16:58:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00653233",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:59:01-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RATIO-LENOLTEC NO 1",
    "en_drug_common_name": "LENOLTEC 1",
    "fr_drug_brand_name": "TEVA-LENOLTEC 1",
    "fr_drug_common_name": "LENOLTEC 1",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "300MG\r\n8MG\r\n15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81368,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17680,
      "drug_code": 78746,
      "updated_date": "2025-12-03T01:25:24-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344754,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8344753,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302152",
      "brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE P)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0222417002"
    },
    "created_date": "2019-04-11T16:59:45-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02302152",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T16:59:56-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE P)",
    "en_drug_common_name": "LISINOPRIL/HCTZ (TYPE P)",
    "fr_drug_brand_name": "TEVA LISINOPRIL/HCTZ (TYPE P)",
    "fr_drug_common_name": "LISINOPRIL/HCTZ (TYPE P)",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLISINOPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nLisinopril",
    "drug_strength": "25MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81371,
    "drug": {
      "current_status": "MARKETED",
      "id": 1696,
      "drug_code": 13654,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251795,
          "ingredient": {
            "id": 916,
            "ingredient_code": 1395,
            "en_name": "FAMOTIDINE",
            "fr_name": "Famotidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02022133",
      "brand_name": "TEVA-FAMOTIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75087",
      "number_of_ais": "1",
      "ai_group_no": "0118722001"
    },
    "created_date": "2019-04-11T17:00:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02022133",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T17:00:48-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-FAMOTIDINE",
    "en_drug_common_name": "FAMOTIDINE",
    "fr_drug_brand_name": "TEVA FAMOTIDINE",
    "fr_drug_common_name": "FAMOTIDINE",
    "en_ingredients": "FAMOTIDINE",
    "fr_ingredients": "Famotidine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81376,
    "drug": {
      "current_status": "MARKETED",
      "id": 7712,
      "drug_code": 507,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250155,
          "ingredient": {
            "id": 714,
            "ingredient_code": 7566,
            "en_name": "PREDNISONE",
            "fr_name": "Prednisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00021695",
      "brand_name": "TEVA-PREDNISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "20724",
      "number_of_ais": "1",
      "ai_group_no": "0106321001"
    },
    "created_date": "2019-04-11T17:01:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00021695",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T17:01:33-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-PREDNISONE",
    "en_drug_common_name": "PREDNISONE",
    "fr_drug_brand_name": "TEVA PREDNISONE",
    "fr_drug_common_name": "PREDNISONE",
    "en_ingredients": "PREDNISONE",
    "fr_ingredients": "Prednisone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81381,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22998,
      "drug_code": 85575,
      "updated_date": "2025-12-03T01:29:15-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350462,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370611",
      "brand_name": "ACT DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863004"
    },
    "created_date": "2019-04-11T17:02:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02370611",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T17:02:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ACT DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "ACT DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81388,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13146,
      "drug_code": 72568,
      "updated_date": "2025-12-03T01:22:19-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338901,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248232",
      "brand_name": "TEVA-LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134003"
    },
    "created_date": "2019-04-11T17:05:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248232",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T17:05:52-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-LAMOTRIGINE",
    "en_drug_common_name": "LAMOTRIGINE",
    "fr_drug_brand_name": "TEVA LAMOTRIGINE",
    "fr_drug_common_name": "LAMOTRIGINE",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81393,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2876,
      "drug_code": 16955,
      "updated_date": "2025-05-15T03:43:06-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8298336,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01934171",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "SUGAR REDUCED",
      "pediatric_flag": false,
      "accession_number": "79069",
      "number_of_ais": "1",
      "ai_group_no": "0131314002"
    },
    "created_date": "2019-04-11T17:06:33-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01934171",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T17:06:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "TEVA AMOXICILLIN SUS",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "25MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "150ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81400,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16268,
      "drug_code": 77060,
      "updated_date": "2025-05-15T04:11:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8343146,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285088",
      "brand_name": "TEVA-LISINOPRIL (TYPE P)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2019-04-11T17:07:53-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02285088",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T17:08:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-LISINOPRIL (TYPE P)",
    "en_drug_common_name": "LISINOPRIL (TYPE P)",
    "fr_drug_brand_name": "TEVA LISINOPRIL (TYPE P)",
    "fr_drug_common_name": "LISINOPRIL (TYPE P)",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81415,
    "drug": {
      "current_status": "MARKETED",
      "id": 10670,
      "drug_code": 66290,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254044,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242539",
      "brand_name": "TEVA-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2019-04-11T17:27:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242539",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2019-05-30T00:00:00-04:00",
    "actual_start_date": "2019-04-11T00:00:00-04:00",
    "actual_end_date": "2019-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-06-03T20:06:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "TEVA-DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81418,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23000,
      "drug_code": 85576,
      "updated_date": "2025-12-03T01:29:15-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350463,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370638",
      "brand_name": "ACT DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2019-04-11T17:39:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02370638",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "discontinuation_date": "2019-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-11T17:40:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ACT DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "TEVA-DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81429,
    "drug": {
      "current_status": "MARKETED",
      "id": 16436,
      "drug_code": 77247,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255863,
          "ingredient": {
            "id": 1148,
            "ingredient_code": 2104,
            "en_name": "BACLOFEN",
            "fr_name": "Baclofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02287048",
      "brand_name": "BACLOFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113246002"
    },
    "created_date": "2019-04-11T18:23:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02287048",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "anticipated_start_date": "2019-04-22T00:00:00-04:00",
    "estimated_end_date": "2019-08-30T00:00:00-04:00",
    "actual_start_date": "2019-04-23T00:00:00-04:00",
    "actual_end_date": "2019-08-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-24T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BACLOFEN",
    "en_drug_common_name": "BACLOFEN",
    "fr_drug_brand_name": "BACLOFEN",
    "fr_drug_common_name": "BACLOFEN",
    "en_ingredients": "BACLOFEN",
    "fr_ingredients": "Baclofène",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81461,
    "drug": {
      "current_status": "MARKETED",
      "id": 30958,
      "drug_code": 93107,
      "updated_date": "2025-12-03T00:32:55-05:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261441,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445794",
      "brand_name": "AURO-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2019-04-11T20:47:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445794",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2024-04-11T00:00:00-04:00",
    "actual_end_date": "2025-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-19T17:16:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CANDESARTAN",
    "en_drug_common_name": "Candesartan Cilexetil",
    "fr_drug_brand_name": "AURO-CANDESARTAN",
    "fr_drug_common_name": "Candésartan cilexétil",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81464,
    "drug": {
      "current_status": "MARKETED",
      "id": 26696,
      "drug_code": 88988,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259627,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02405040",
      "brand_name": "AURO-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2019-04-11T20:49:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02405040",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2019-04-11T00:00:00-04:00",
    "actual_end_date": "2019-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-14T20:23:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-VALACYCLOVIR",
    "en_drug_common_name": "Valacyclovir",
    "fr_drug_brand_name": "AURO-VALACYCLOVIR",
    "fr_drug_common_name": "Valacyclovir",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "Valacyclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81471,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6370,
      "drug_code": 43283,
      "updated_date": "2025-05-15T03:49:51-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8312888,
          "ingredient": {
            "id": 1514,
            "ingredient_code": 2007,
            "en_name": "BROMAZEPAM",
            "fr_name": "Bromazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02220539",
      "brand_name": "BROMAZEPAM-6 - TAB 6MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9614",
      "number_of_ais": "1",
      "ai_group_no": "0114488001"
    },
    "created_date": "2019-04-11T22:56:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02220539",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2019-06-27T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-06-28T05:00:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BROMAZEPAM-6 - TAB 6MG",
    "en_drug_common_name": "BROMAZEPAM-6 - TAB 6MG",
    "fr_drug_brand_name": "BROMAZEPAM-6 TAB 6MG",
    "fr_drug_common_name": "BROMAZEPAM-6",
    "en_ingredients": "BROMAZEPAM",
    "fr_ingredients": "Bromazépam",
    "drug_strength": "6MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81487,
    "drug": {
      "current_status": "MARKETED",
      "id": 334,
      "drug_code": 10865,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 17330,
        "created_date": "2024-05-09T01:45:09-04:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 19068,
        "mfr_code": "",
        "name": "VANTIVE ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6675 MILLCREEK DRIVE, UNIT 2",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 5M4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251422,
          "ingredient": {
            "id": 12,
            "ingredient_code": 49,
            "en_name": "MAGNESIUM CHLORIDE",
            "fr_name": "Chlorure de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.08",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251421,
          "ingredient": {
            "id": 8,
            "ingredient_code": 1074,
            "en_name": "SODIUM LACTATE",
            "fr_name": "Lactate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "448",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251420,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "538",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251419,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.25",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251418,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18.3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00865117",
      "brand_name": "DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70982",
      "number_of_ais": "5",
      "ai_group_no": "0500162030"
    },
    "created_date": "2019-04-12T14:01:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00865117",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05ZA",
    "atc_description": "HEMODIALYTICS AND HEMOFILTRATES",
    "anticipated_start_date": "2019-04-12T00:00:00-04:00",
    "estimated_end_date": "2019-04-29T00:00:00-04:00",
    "actual_start_date": "2019-04-12T00:00:00-04:00",
    "actual_end_date": "2019-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-30T05:00:01-04:00",
    "status": "resolved",
    "en_comments": "Customer care will assess inventory on hand at time of order placement.  If there is not enough inventory on hand to last until new stock is available, we have a substitute code available JB4771L (DIANEAL, PD4 4.25% 3L SYSII) as well as CJPE8282 (PHYSIONEAL 40 3.86% 5L SINGLE). Prescribers will have the option to make prescription adjustments to accommodate our 3L offering of the same formulation for APD.",
    "fr_comments": "Le service à la clientèle vérifiera le stock disponible au moment de la commande. Si les stocks disponibles sont insuffisants pour subvenir aux besoins jusqu’à la réception de nouvelles provisions, un code de rechange est proposé JB4771L (DIANEAL, PD4 4,25 % 3 L SYSII) et CJPE8282 (PHYSIONEAL 40 3.86% 5L SINGLE). Les prescripteurs disposeront de la possibilité d’ajuster l’ordonnance pour s’adapter à notre produit de 3 L de la même formulation pour la DPA.",
    "en_drug_brand_name": "DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM",
    "en_drug_common_name": "Dianeal PD4",
    "fr_drug_brand_name": "Dianeal PD4",
    "fr_drug_common_name": "Dianeal PD4",
    "en_ingredients": "SODIUM LACTATE\r\nDEXTROSE\r\nMAGNESIUM CHLORIDE\r\nCALCIUM CHLORIDE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Lactate de sodium\r\nDextrose\r\nChlorure de magnésium\r\nChlorure de calcium\r\nChlorure de sodium",
    "drug_strength": "448MG\r\n4.25G\r\n5.08MG\r\n18.3MG\r\n538MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "DIALYSIS",
    "drug_route_fr": "Dialyse",
    "drug_package_quantity": "5L",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81528,
    "drug": {
      "current_status": "MARKETED",
      "id": 22526,
      "drug_code": 85004,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258089,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365197",
      "brand_name": "IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2019-04-12T19:05:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365197",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2019-04-12T00:00:00-04:00",
    "actual_end_date": "2019-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81530,
    "drug": {
      "current_status": "MARKETED",
      "id": 22526,
      "drug_code": 85004,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258089,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365197",
      "brand_name": "IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2019-04-12T19:06:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365197",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2019-04-12T00:00:00-04:00",
    "actual_end_date": "2019-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81534,
    "drug": {
      "current_status": "MARKETED",
      "id": 4720,
      "drug_code": 2481,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 644,
        "created_date": "2017-03-09T13:23:00-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15112,
        "mfr_code": "",
        "name": "SANOFI CONSUMER HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2905 PLACE LOUIS-R RENAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7V 0A3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250419,
          "ingredient": {
            "id": 1754,
            "ingredient_code": 9008,
            "en_name": "HYOSCINE BUTYLBROMIDE",
            "fr_name": "Butylbromure d'hyoscine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00363812",
      "brand_name": "BUSCOPAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49802",
      "number_of_ais": "1",
      "ai_group_no": "0104703001"
    },
    "created_date": "2019-04-12T20:07:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00363812",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A03BB",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "anticipated_start_date": "2019-04-15T00:00:00-04:00",
    "estimated_end_date": "2019-09-01T00:00:00-04:00",
    "actual_start_date": "2019-04-04T00:00:00-04:00",
    "actual_end_date": "2019-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-07-16T20:08:03-04:00",
    "status": "resolved",
    "en_comments": "Delay in manufacturing",
    "fr_comments": "Délai de fabrication",
    "en_drug_brand_name": "BUSCOPAN",
    "en_drug_common_name": "Buscopan",
    "fr_drug_brand_name": "BUSCOPAN",
    "fr_drug_common_name": "Buscopan",
    "en_ingredients": "HYOSCINE BUTYLBROMIDE",
    "fr_ingredients": "Butylbromure d'hyoscine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81611,
    "drug": {
      "current_status": "MARKETED",
      "id": 51759,
      "drug_code": 95265,
      "updated_date": "2025-05-15T02:35:52-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262531,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8262530,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02464519",
      "brand_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561001"
    },
    "created_date": "2019-04-15T14:27:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464519",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2019-04-26T00:00:00-04:00",
    "actual_start_date": "2019-04-04T00:00:00-04:00",
    "actual_end_date": "2019-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-29T14:31:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
    "en_drug_common_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
    "fr_drug_brand_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
    "fr_drug_common_name": "TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT",
    "en_ingredients": "BENZOYL PEROXIDE\r\nCLINDAMYCIN",
    "fr_ingredients": "Peroxyde de benzoyle",
    "drug_strength": "5%\r\n1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "50g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81614,
    "drug": {
      "current_status": "MARKETED",
      "id": 30628,
      "drug_code": 9268,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251138,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716626",
      "brand_name": "BETADERM CRM 0.1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68220",
      "number_of_ais": "1",
      "ai_group_no": "0106299001"
    },
    "created_date": "2019-04-15T14:29:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716626",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2019-05-17T00:00:00-04:00",
    "actual_start_date": "2019-04-05T00:00:00-04:00",
    "actual_end_date": "2019-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-04T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BETADERM CRM 0.1%",
    "en_drug_common_name": "BETADERM CREAM",
    "fr_drug_brand_name": "BETADERM CREAM",
    "fr_drug_common_name": "BETADERM CREAM",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "454 G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81617,
    "drug": {
      "current_status": "MARKETED",
      "id": 21470,
      "drug_code": 83849,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257670,
          "ingredient": {
            "id": 3128,
            "ingredient_code": 12378,
            "en_name": "CICLOPIROX",
            "fr_name": "Ciclopirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02353288",
      "brand_name": "TARO-CICLOPIROX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150022001"
    },
    "created_date": "2019-04-15T14:30:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353288",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D01AE",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "estimated_end_date": "2019-08-16T00:00:00-04:00",
    "actual_start_date": "2019-04-11T00:00:00-04:00",
    "actual_end_date": "2019-08-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-10T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CICLOPIROX",
    "en_drug_common_name": "TARO-CICLOPIROX",
    "fr_drug_brand_name": "TARO-CICLOPIROX",
    "fr_drug_common_name": "TARO-CICLOPIROX",
    "en_ingredients": "CICLOPIROX",
    "fr_ingredients": "Ciclopirox",
    "drug_strength": "8%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "6 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81620,
    "drug": {
      "current_status": "MARKETED",
      "id": 53877,
      "drug_code": 95190,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262486,
          "ingredient": {
            "id": 2508,
            "ingredient_code": 7485,
            "en_name": "TESTOSTERONE",
            "fr_name": "Testostérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02463806",
      "brand_name": "TARO-TESTOSTERONE GEL",
      "brand_name_fr": "",
      "descriptor": "5 G GEL PER PACK",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106405004"
    },
    "created_date": "2019-04-15T14:31:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02463806",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "G03BA",
    "atc_description": "ANDROGENS",
    "estimated_end_date": "2019-05-03T00:00:00-04:00",
    "actual_start_date": "2019-04-11T00:00:00-04:00",
    "actual_end_date": "2019-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-03T19:14:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-TESTOSTERONE GEL",
    "en_drug_common_name": "TARO-TESTOSTERONE GEL",
    "fr_drug_brand_name": "TARO-TESTOSTERONE GEL",
    "fr_drug_common_name": "TARO-TESTOSTERONE GEL",
    "en_ingredients": "TESTOSTERONE",
    "fr_ingredients": "Testostérone",
    "drug_strength": "1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "5 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81623,
    "drug": {
      "current_status": "MARKETED",
      "id": 31940,
      "drug_code": 9449,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251172,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251171,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251170,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251169,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": true
        }
      ],
      "din": "00717029",
      "brand_name": "VIADERM KC ONT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68587",
      "number_of_ais": "4",
      "ai_group_no": "0405625002"
    },
    "created_date": "2019-04-15T14:32:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00717029",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07CB",
    "atc_description": "CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",
    "estimated_end_date": "2019-05-10T00:00:00-04:00",
    "actual_start_date": "2019-04-09T00:00:00-04:00",
    "actual_end_date": "2019-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-04T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VIADERM KC ONT",
    "en_drug_common_name": "VIADERM KC ONT",
    "fr_drug_brand_name": "VIADERM KC ONT",
    "fr_drug_common_name": "VIADERM KC ONT",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE\r\nNYSTATIN\r\nGRAMICIDIN\r\nNEOMYCIN",
    "fr_ingredients": "Acétonide  de triamcinolone\r\nNystatine\r\nGramicidine\r\nNéomycine",
    "drug_strength": "1MG\r\n100000UNIT\r\n0.25MG\r\n2.5MG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "30 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81626,
    "drug": {
      "current_status": "MARKETED",
      "id": 8630,
      "drug_code": 60295,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253492,
          "ingredient": {
            "id": 478,
            "ingredient_code": 7579,
            "en_name": "FLUOCINONIDE",
            "fr_name": "Fluocinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236997",
      "brand_name": "LYDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106313001"
    },
    "created_date": "2019-04-15T14:33:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236997",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2019-04-26T00:00:00-04:00",
    "actual_start_date": "2019-03-29T00:00:00-04:00",
    "actual_end_date": "2019-04-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-23T18:04:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LYDERM GEL 0.05%",
    "en_drug_common_name": "LYDERM GEL 0.05%",
    "fr_drug_brand_name": "LYDERM GEL 0.05%",
    "fr_drug_common_name": "LYDERM GEL 0.05%",
    "en_ingredients": "FLUOCINONIDE",
    "fr_ingredients": "Fluocinonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81678,
    "drug": {
      "current_status": "MARKETED",
      "id": 16804,
      "drug_code": 77763,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255937,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02292270",
      "brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292007"
    },
    "created_date": "2019-04-15T20:29:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292270",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2019-04-18T00:00:00-04:00",
    "actual_end_date": "2019-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-09-10T14:45:12-04:00",
    "status": "resolved",
    "en_comments": "Limited supply . Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "fr_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "en_drug_brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
    "en_drug_common_name": "CEFTRIAXONE",
    "fr_drug_brand_name": "CEFTRIAXONE",
    "fr_drug_common_name": "CEFTRIAXONE",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "CEFTRIAXONE",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81686,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25958,
      "drug_code": 88338,
      "updated_date": "2025-05-15T04:20:50-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8352503,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02398427",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "50MG/2ML & 500MG/20ML VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2019-04-15T20:33:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398427",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "hc_updated_date": "2023-11-17T17:55:33-05:00",
    "actual_start_date": "2019-03-25T00:00:00-04:00",
    "actual_end_date": "2023-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-11-17T17:55:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "METHOTREXATE",
    "fr_drug_brand_name": "METHOTREXATE",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRA-ARTERIAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intra-artérielle\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "20ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81730,
    "drug": {
      "current_status": "MARKETED",
      "id": 55896,
      "drug_code": 95940,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262900,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262899,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470438",
      "brand_name": "SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401001"
    },
    "created_date": "2019-04-15T21:01:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470438",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2019-05-20T00:00:00-04:00",
    "actual_start_date": "2019-03-25T00:00:00-04:00",
    "actual_end_date": "2019-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-06-28T21:22:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE",
    "en_drug_common_name": "Perindopril Erbu/Inda",
    "fr_drug_brand_name": "Perindopril Erbu/Inda",
    "fr_drug_common_name": "Perindopril Erbu/Inda",
    "en_ingredients": "PERINDOPRIL ERBUMINE\r\nINDAPAMIDE",
    "fr_ingredients": "Périndopril erbumine\r\nIndapamide",
    "drug_strength": "4MG\r\n1.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81743,
    "drug": {
      "current_status": "MARKETED",
      "id": 27372,
      "drug_code": 89614,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259903,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02411520",
      "brand_name": "SANDOZ MOXIFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242003"
    },
    "created_date": "2019-04-15T21:08:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411520",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01AE",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2019-05-13T00:00:00-04:00",
    "actual_start_date": "2019-03-11T00:00:00-04:00",
    "actual_end_date": "2019-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-06-28T21:25:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MOXIFLOXACIN",
    "en_drug_common_name": "MOXIFLOXACIN",
    "fr_drug_brand_name": "MOXIFLOXACIN",
    "fr_drug_common_name": "MOXIFLOXACIN",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "MOXIFLOXACIN",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81748,
    "drug": {
      "current_status": "MARKETED",
      "id": 1848,
      "drug_code": 13946,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251844,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01916203",
      "brand_name": "SANDOZ PREDNISOLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75429",
      "number_of_ais": "1",
      "ai_group_no": "0106295001"
    },
    "created_date": "2019-04-15T21:10:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01916203",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2019-07-12T00:00:00-04:00",
    "actual_start_date": "2019-04-08T00:00:00-04:00",
    "actual_end_date": "2019-07-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-07-24T14:14:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREDNISOLONE",
    "en_drug_common_name": "PREDNISOLONE",
    "fr_drug_brand_name": "PREDNISOLONE",
    "fr_drug_common_name": "PREDNISOLONE",
    "en_ingredients": "PREDNISOLONE ACETATE",
    "fr_ingredients": "Acétate de prednisolone",
    "drug_strength": "1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81781,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 58664,
      "drug_code": 81344,
      "updated_date": "2025-05-15T04:14:47-04:00",
      "company": {
        "id": 918,
        "created_date": "2017-03-09T13:23:27-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 13433,
        "mfr_code": "",
        "name": "LANTHEUS MI CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2X6",
        "post_office_box": "",
        "contact_information": "lmicanada@lantheus.com\r\n1-800-811-5500"
      },
      "drug_ingredients": [
        {
          "id": 8347155,
          "ingredient": {
            "id": 14561,
            "ingredient_code": 8045,
            "en_name": "THALLIUM CHLORIDE",
            "fr_name": "Chlorure de thallium (TI 201)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MCI",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "Not Applicable/non applicable",
      "brand_name": "THALLIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152598001"
    },
    "created_date": "2019-04-16T15:55:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327945",
    "company_name": "LANTHEUS MI CANADA INC",
    "atc_number": "V09GX",
    "actual_start_date": "2019-03-15T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-11T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "THALLIUM",
    "en_drug_common_name": "Tl-201 Injection",
    "fr_drug_brand_name": "THALLIUM",
    "fr_drug_common_name": "Tl-201 Injection",
    "en_ingredients": "THALLIUM CHLORIDE",
    "fr_ingredients": "THALLIUM CHLORIDE",
    "drug_strength": "2MCI",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10mL glass vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81791,
    "drug": {
      "current_status": "DORMANT",
      "id": 30582,
      "drug_code": 9264,
      "updated_date": "2025-05-15T06:55:22-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366537,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00742554",
      "brand_name": "ISOPTIN SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68215",
      "number_of_ais": "1",
      "ai_group_no": "0113846003"
    },
    "created_date": "2019-04-16T17:27:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00742554",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C08DA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2019-06-28T00:00:00-04:00",
    "actual_start_date": "2019-04-16T00:00:00-04:00",
    "actual_end_date": "2019-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ISOPTIN SR",
    "en_drug_common_name": "VERAPAMIL HYDROCHLORIDE",
    "fr_drug_brand_name": "ISOPTIN",
    "fr_drug_common_name": "VERAPAMIL HYDROCHLORIDE",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "240MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81794,
    "drug": {
      "current_status": "MARKETED",
      "id": 60428,
      "drug_code": 95239,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262509,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464225",
      "brand_name": "MYLAN-VARDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003002"
    },
    "created_date": "2019-04-16T17:36:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464225",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "estimated_end_date": "2019-07-30T00:00:00-04:00",
    "actual_start_date": "2019-04-16T00:00:00-04:00",
    "actual_end_date": "2019-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-23T11:04:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VARDENAFIL",
    "en_drug_common_name": "VARDENAFIL",
    "fr_drug_brand_name": "MYLAN-VARDENAFIL",
    "fr_drug_common_name": "VARDENAFIL",
    "fr_ingredients": "VARDENAFIL",
    "drug_dosage_form_fr": "TABLETS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "4 BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81807,
    "drug": {
      "current_status": "MARKETED",
      "id": 21286,
      "drug_code": 83683,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8257540,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351579",
      "brand_name": "MYLAN-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2019-04-16T17:43:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351579",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2019-04-24T00:00:00-04:00",
    "estimated_end_date": "2019-05-17T00:00:00-04:00",
    "actual_end_date": "2019-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-VALACYCLOVIR",
    "fr_drug_common_name": "VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81810,
    "drug": {
      "current_status": "MARKETED",
      "id": 21288,
      "drug_code": 83684,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8257541,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351560",
      "brand_name": "MYLAN-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626003"
    },
    "created_date": "2019-04-16T17:44:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351560",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2019-05-16T00:00:00-04:00",
    "estimated_end_date": "2019-05-17T00:00:00-04:00",
    "actual_end_date": "2019-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-04-30T18:52:54-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-VALACYCLOVIR",
    "fr_drug_common_name": "VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81825,
    "drug": {
      "current_status": "MARKETED",
      "id": 6784,
      "drug_code": 44264,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253181,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02182971",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "METHOTREXATE INJECTABLE USP",
      "descriptor": "PRESERVATIVE-FREE (PHARMACY BULK VIAL)",
      "pediatric_flag": false,
      "accession_number": "T9988",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2019-04-16T17:53:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182971",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2019-04-19T00:00:00-04:00",
    "estimated_end_date": "2019-05-31T00:00:00-04:00",
    "actual_start_date": "2019-04-24T00:00:00-04:00",
    "actual_end_date": "2019-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-28T19:35:28-04:00",
    "status": "resolved",
    "en_comments": "Other presentation are available",
    "fr_comments": "D'autres présentations sont disponibles",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "Methotrexate",
    "fr_drug_brand_name": "METHOTREXATE INJECTION USP",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "100mL Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81833,
    "drug": {
      "current_status": "MARKETED",
      "id": 29844,
      "drug_code": 91886,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260820,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434539",
      "brand_name": "MYLAN-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282001"
    },
    "created_date": "2019-04-16T17:56:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434539",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "anticipated_start_date": "2019-05-07T00:00:00-04:00",
    "estimated_end_date": "2019-06-21T00:00:00-04:00",
    "actual_start_date": "2019-05-07T00:00:00-04:00",
    "actual_end_date": "2019-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-06-19T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CINACALCET",
    "en_drug_common_name": "CINACALCET",
    "fr_drug_brand_name": "MYLAN-CINACALCET",
    "fr_drug_common_name": "CINACALCET",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "CINACALCET",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81836,
    "drug": {
      "current_status": "MARKETED",
      "id": 26842,
      "drug_code": 89112,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259670,
          "ingredient": {
            "id": 26,
            "ingredient_code": 10146,
            "en_name": "HALOPERIDOL",
            "fr_name": "Halopéridol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02406411",
      "brand_name": "HALOPERIDOL INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "1ML & 10 ML MULTIDOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101774001"
    },
    "created_date": "2019-04-16T18:38:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02406411",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05AD",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2019-04-23T00:00:00-04:00",
    "estimated_end_date": "2019-06-24T00:00:00-04:00",
    "actual_end_date": "2019-07-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-06T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Replenishment inventories of our Haloperidol Injection, USP\r\n5mg/mL MD Vial 1 mL will be available at all distribution centres on Friday, July 5, 2019",
    "fr_comments": "Cette présentation du produit sera disponible auprès de tous nos\r\ncentres de distribution dès ce vendredi, 5 juillet 2019.",
    "en_drug_brand_name": "HALOPERIDOL INJECTION, USP",
    "en_drug_common_name": "Haloperidol",
    "fr_drug_brand_name": "Halopéridol injectable",
    "fr_drug_common_name": "Halopéridol",
    "en_ingredients": "HALOPERIDOL",
    "fr_ingredients": "Halopéridol",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81842,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 58658,
      "drug_code": 81316,
      "updated_date": "2025-05-15T04:14:47-04:00",
      "company": {
        "id": 918,
        "created_date": "2017-03-09T13:23:27-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 13433,
        "mfr_code": "",
        "name": "LANTHEUS MI CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2X6",
        "post_office_box": "",
        "contact_information": "lmicanada@lantheus.com\r\n1-800-811-5500"
      },
      "drug_ingredients": [
        {
          "id": 8347146,
          "ingredient": {
            "id": 14565,
            "ingredient_code": 8044,
            "en_name": "GALLIUM CITRATE GA 67",
            "fr_name": "Citrate de gallium 67 GA"
          },
          "ingredient_supplied_ind": "I",
          "strength": "74",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "Not Applicable/non applicable",
      "brand_name": "GALLIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152589005"
    },
    "created_date": "2019-04-16T20:47:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327759",
    "company_name": "LANTHEUS MI CANADA INC",
    "atc_number": "V09HX",
    "actual_start_date": "2019-04-04T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-11T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GALLIUM",
    "en_drug_common_name": "Gallium Citrate Ga-67 Injection",
    "fr_drug_brand_name": "GALLIUM",
    "fr_drug_common_name": "Gallium Citrate Ga-67 Injection",
    "en_ingredients": "GALLIUM CITRATE GA 67",
    "fr_ingredients": "GALLIUM CITRATE GA-67",
    "drug_strength": "74MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81900,
    "drug": {
      "current_status": "MARKETED",
      "id": 30296,
      "drug_code": 92354,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261067,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439166",
      "brand_name": "NAT-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2019-04-17T15:50:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439166",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2019-05-01T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-07-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NAT-QUETIAPINE",
    "en_drug_common_name": "Quetiapine Tablets",
    "fr_drug_brand_name": "NAT-Quetiapine",
    "fr_drug_common_name": "Quetiapine Comprime",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81903,
    "drug": {
      "current_status": "MARKETED",
      "id": 30300,
      "drug_code": 92356,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261069,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439182",
      "brand_name": "NAT-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2019-04-17T15:52:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439182",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2019-05-01T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-07-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NAT-QUETIAPINE",
    "en_drug_common_name": "Quetiapine Tablets",
    "fr_drug_brand_name": "NAT-Quetiapine",
    "fr_drug_common_name": "Quetiapine Comprime",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81906,
    "drug": {
      "current_status": "MARKETED",
      "id": 30302,
      "drug_code": 92357,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261070,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439190",
      "brand_name": "NAT-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2019-04-17T15:53:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439190",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2019-05-01T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-07-01T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NAT-QUETIAPINE",
    "en_drug_common_name": "Quetiapine Tablets",
    "fr_drug_brand_name": "NAT-Quetiapine",
    "fr_drug_common_name": "Quetiapine Comprime",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81921,
    "drug": {
      "current_status": "MARKETED",
      "id": 30412,
      "drug_code": 92460,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261112,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440229",
      "brand_name": "NAT-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2019-04-17T15:57:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440229",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2019-08-01T00:00:00-04:00",
    "actual_end_date": "2021-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NAT-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM Tablets",
    "fr_drug_brand_name": "NAT-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM comprime",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81926,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 55471,
      "drug_code": 96047,
      "updated_date": "2025-05-15T04:25:29-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357666,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471353",
      "brand_name": "RIVA-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496002"
    },
    "created_date": "2019-04-17T17:28:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02471353",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2019-04-17T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 2,
      "en_reason": "Raw material availability",
      "fr_reason": "Disponibilité des matières premières",
      "active": true
    },
    "updated_date": "2019-04-18T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RIVA-OLMESARTAN",
    "en_drug_common_name": "Riva-olmesartan 20mg",
    "fr_drug_brand_name": "Riva-Olmesartan",
    "fr_drug_common_name": "Riva-Olmesartan 20mg",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Olmesartan",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 & 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81929,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 55473,
      "drug_code": 96048,
      "updated_date": "2025-05-15T04:25:29-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357667,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471361",
      "brand_name": "RIVA-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2019-04-17T17:31:57-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02471361",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "discontinuation_date": "2019-04-17T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 2,
      "en_reason": "Raw material availability",
      "fr_reason": "Disponibilité des matières premières",
      "active": true
    },
    "updated_date": "2019-04-18T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RIVA-OLMESARTAN",
    "en_drug_common_name": "Riva- Olmesartan 40mg",
    "fr_drug_brand_name": "Riva - Olmesartan",
    "fr_drug_common_name": "Riva- Olmesartan 40mg",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Olmesartan Medoxomil",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 & 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81954,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 178,
      "drug_code": 10485,
      "updated_date": "2025-05-15T03:37:09-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8286771,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00705799",
      "brand_name": "STATEX DPS 50MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70388",
      "number_of_ais": "1",
      "ai_group_no": "0104545006"
    },
    "created_date": "2019-04-17T19:44:24-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00705799",
    "company_name": "PALADIN LABS INC",
    "discontinuation_date": "2018-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2019-04-18T13:58:56-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "STATEX DPS 50MG/ML",
    "en_drug_common_name": "Morphine Sulfate",
    "fr_drug_brand_name": "STATEX 50mg/ml GTE 50ml",
    "fr_drug_common_name": "MORPHINE SULFATE",
    "fr_ingredients": "MORPHINE SULFATE",
    "drug_dosage_form_fr": "50mL",
    "drug_route_fr": "Gouttes",
    "drug_package_quantity": "50mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81959,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2582,
      "drug_code": 16178,
      "updated_date": "2025-05-15T03:42:24-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8296605,
          "ingredient": {
            "id": 1236,
            "ingredient_code": 521,
            "en_name": "IOPROMIDE",
            "fr_name": "Iopromide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02078597",
      "brand_name": "ULTRAVIST 240",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77965",
      "number_of_ais": "1",
      "ai_group_no": "0125805001"
    },
    "created_date": "2019-04-17T21:50:10-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02078597",
    "company_name": "BAYER INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "discontinuation_date": "2019-04-16T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-17T21:51:14-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ULTRAVIST 240",
    "en_drug_common_name": "Iopromide",
    "fr_drug_brand_name": "Ultravist",
    "fr_drug_common_name": "Iopromide",
    "en_ingredients": "IOPROMIDE",
    "fr_ingredients": "Iopromide",
    "drug_strength": "50%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR",
    "drug_route_fr": "Intravasculaire",
    "drug_package_quantity": "50 & 200ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81977,
    "drug": {
      "current_status": "MARKETED",
      "id": 23858,
      "drug_code": 86520,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258586,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379325",
      "brand_name": "MONTELUKAST",
      "brand_name_fr": "MONTÉLUKAST",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2019-04-18T11:32:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379325",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "actual_start_date": "2019-04-18T00:00:00-04:00",
    "actual_end_date": "2024-12-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-04T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "This report pertains to a currently inactive molecule from 2019 that was not closed at that time. As it is now outdated and no longer actionable, we are closing it.",
    "fr_comments": "This report pertains to a currently inactive molecule from 2019 that was not closed at that time. As it is now outdated and no longer actionable, we are closing it.",
    "en_drug_brand_name": "MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81981,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23856,
      "drug_code": 86519,
      "updated_date": "2025-05-15T04:19:49-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351202,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379317",
      "brand_name": "MONTELUKAST",
      "brand_name_fr": "MONTÉLUKAST",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823003"
    },
    "created_date": "2019-04-18T11:36:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379317",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "actual_start_date": "2019-04-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-19T05:00:02-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81989,
    "drug": {
      "current_status": "MARKETED",
      "id": 17366,
      "drug_code": 78412,
      "updated_date": "2025-05-15T02:31:59-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8256123,
          "ingredient": {
            "id": 3412,
            "ingredient_code": 20156,
            "en_name": "APREPITANT",
            "fr_name": "Aprépitant"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256122,
          "ingredient": {
            "id": 3412,
            "ingredient_code": 20156,
            "en_name": "APREPITANT",
            "fr_name": "Aprépitant"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298813",
      "brand_name": "EMEND TRI-PACK",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252291001"
    },
    "created_date": "2019-04-18T13:07:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298813",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "anticipated_start_date": "2019-08-09T00:00:00-04:00",
    "estimated_end_date": "2019-08-19T00:00:00-04:00",
    "actual_end_date": "2019-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-08-06T15:50:31-04:00",
    "status": "avoided_shortage",
    "en_comments": "Other individual formats (80MG 2CAP & 125MG 6CAP) are not affected",
    "fr_comments": "Les autres formats individuels (80MG 2CAP & 125MG 6CAP) ne sont pas impactés",
    "en_drug_brand_name": "EMEND TRI-PACK",
    "en_drug_common_name": "aprepitant capsules",
    "fr_drug_brand_name": "EMEND",
    "fr_drug_common_name": "gélules d’aprépitant",
    "en_ingredients": "APREPITANT\r\nAPREPITANT",
    "fr_ingredients": "Aprépitant\r\nAprépitant",
    "drug_strength": "125MG\r\n80MG",
    "drug_dosage_form": "KIT\r\nCAPSULE",
    "drug_dosage_form_fr": "Trousse\r\nCapsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3cap",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 81996,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8960,
      "drug_code": 6134,
      "updated_date": "2025-05-15T03:29:30-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8279862,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00591467",
      "brand_name": "STATEX SYRUP 1MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62375",
      "number_of_ais": "1",
      "ai_group_no": "0104545004"
    },
    "created_date": "2019-04-18T14:08:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00591467",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-05-29T00:00:00-04:00",
    "anticipated_discontinuation_date": "2019-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2019-07-05T18:08:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "STATEX SYRUP 1MG/ML",
    "en_drug_common_name": "Morphine Sulfate",
    "fr_drug_brand_name": "STATEX 1mg/mL SIR 500mL",
    "fr_drug_common_name": "MORPHINE SULFATE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82013,
    "drug": {
      "current_status": "MARKETED",
      "id": 17030,
      "drug_code": 78058,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256006,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295261",
      "brand_name": "APO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2019-04-18T16:41:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295261",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-05-06T00:00:00-04:00",
    "actual_start_date": "2019-04-15T00:00:00-04:00",
    "actual_end_date": "2019-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-06T14:11:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "APO-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82016,
    "drug": {
      "current_status": "DORMANT",
      "id": 17944,
      "drug_code": 79042,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368125,
          "ingredient": {
            "id": 2466,
            "ingredient_code": 11561,
            "en_name": "OLOPATADINE",
            "fr_name": "Olopatadine (Chlorhydrate d'olopatadine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02305054",
      "brand_name": "APO-OLOPATADINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132394001"
    },
    "created_date": "2019-04-18T16:44:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305054",
    "company_name": "APOTEX INC",
    "atc_number": "S01GX",
    "atc_description": "DECONGESTANTS AND ANTIALLERGICS",
    "estimated_end_date": "2019-06-28T00:00:00-04:00",
    "actual_start_date": "2019-04-15T00:00:00-04:00",
    "actual_end_date": "2019-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-24T13:39:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLOPATADINE",
    "en_drug_common_name": "OLOPATADINE",
    "fr_drug_brand_name": "APO-OLOPATADINE",
    "fr_drug_common_name": "OLOPATADINE",
    "en_ingredients": "OLOPATADINE",
    "fr_ingredients": "OLOPATADINE",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82019,
    "drug": {
      "current_status": "MARKETED",
      "id": 20624,
      "drug_code": 82365,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257290,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338009",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2019-04-18T16:46:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338009",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-05-13T00:00:00-04:00",
    "actual_start_date": "2019-04-15T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-13T18:26:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82022,
    "drug": {
      "current_status": "DORMANT",
      "id": 20290,
      "drug_code": 81739,
      "updated_date": "2025-05-15T06:55:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368359,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02331691",
      "brand_name": "APO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2019-04-18T16:47:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02331691",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2019-06-07T00:00:00-04:00",
    "actual_start_date": "2019-04-15T00:00:00-04:00",
    "actual_end_date": "2019-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-21T17:16:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR",
    "fr_drug_brand_name": "APO-VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE XR",
    "drug_strength": "75.0MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82069,
    "drug": {
      "current_status": "MARKETED",
      "id": 7294,
      "drug_code": 49290,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253268,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230420",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238005"
    },
    "created_date": "2019-04-18T20:21:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230420",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2019-05-20T00:00:00-04:00",
    "actual_start_date": "2019-04-23T00:00:00-04:00",
    "actual_end_date": "2019-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-17T17:08:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX NASAL SPRAY",
    "en_drug_common_name": "sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX NASAL SPRAY",
    "fr_drug_common_name": "vaporisation nasale de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan",
    "drug_strength": "20MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "2's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82076,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17314,
      "drug_code": 78360,
      "updated_date": "2025-05-15T04:12:50-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8344424,
          "ingredient": {
            "id": 3368,
            "ingredient_code": 20097,
            "en_name": "VARENICLINE",
            "fr_name": "Varénicline (Tartrate de varénicline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8344423,
          "ingredient": {
            "id": 3368,
            "ingredient_code": 20097,
            "en_name": "VARENICLINE",
            "fr_name": "Varénicline (Tartrate de varénicline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298309",
      "brand_name": "CHAMPIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252269001"
    },
    "created_date": "2019-04-18T20:52:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298309",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N07BA",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "anticipated_start_date": "2019-04-23T00:00:00-04:00",
    "estimated_end_date": "2019-05-31T00:00:00-04:00",
    "actual_end_date": "2019-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-31T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Other presentations available",
    "fr_comments": "D'autres présentations sont disponibles",
    "en_drug_brand_name": "CHAMPIX",
    "en_drug_common_name": "Champix",
    "fr_drug_brand_name": "CHAMPIX",
    "fr_drug_common_name": "Champix",
    "en_ingredients": "VARENICLINE\r\nVARENICLINE",
    "fr_ingredients": "VARENICLINE VARENICLINE",
    "drug_strength": "0.5MG\r\n1.0MG",
    "drug_dosage_form": "KIT\r\nTABLET",
    "drug_dosage_form_fr": "Trousse\r\nComprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1x11+3x14 COMBO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82102,
    "drug": {
      "current_status": "MARKETED",
      "id": 26080,
      "drug_code": 88441,
      "updated_date": "2025-05-15T02:33:46-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259405,
          "ingredient": {
            "id": 1582,
            "ingredient_code": 122,
            "en_name": "LAMIVUDINE",
            "fr_name": "Lamivudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259404,
          "ingredient": {
            "id": 2704,
            "ingredient_code": 11893,
            "en_name": "ABACAVIR",
            "fr_name": "Abacavir (Sulfate d'abacavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399539",
      "brand_name": "APO-ABACAVIR-LAMIVUDINE",
      "brand_name_fr": "APO-ABACAVIR-LAMIVUDINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251241001"
    },
    "created_date": "2019-04-22T13:08:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02399539",
    "company_name": "APOTEX INC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2019-08-09T00:00:00-04:00",
    "actual_start_date": "2019-04-17T00:00:00-04:00",
    "actual_end_date": "2019-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-29T13:02:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ABACAVIR-LAMIVUDINE",
    "en_drug_common_name": "ABACAVIR-LAMIVUDINE",
    "fr_drug_brand_name": "APO-ABACAVIR-LAMIVUDINE",
    "fr_drug_common_name": "ABACAVIR-LAMIVUDINE",
    "en_ingredients": "ABACAVIR\r\nLAMIVUDINE",
    "fr_ingredients": "Lamivudine",
    "drug_strength": "600MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82135,
    "drug": {
      "current_status": "MARKETED",
      "id": 24472,
      "drug_code": 87096,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258837,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258836,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385325",
      "brand_name": "IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086002"
    },
    "created_date": "2019-04-22T14:26:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385325",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2019-05-06T00:00:00-04:00",
    "estimated_end_date": "2019-06-21T00:00:00-04:00",
    "actual_start_date": "2019-05-01T00:00:00-04:00",
    "actual_end_date": "2019-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-06-22T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN HCT",
    "en_drug_common_name": "IRBESARTAN HCT",
    "fr_drug_brand_name": "IRBESARTAN HCT",
    "fr_drug_common_name": "IRBESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82164,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29072,
      "drug_code": 91111,
      "updated_date": "2025-12-03T01:32:22-05:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8354821,
          "ingredient": {
            "id": 3978,
            "ingredient_code": 20599,
            "en_name": "INFLUENZA VIRUS TYPE A",
            "fr_name": "Virus de l'Influenza de type A (H3N2)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32000000",
          "strength_unit": "FFU",
          "strength_type": "",
          "dosage_value": "0.2",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8354820,
          "ingredient": {
            "id": 3976,
            "ingredient_code": 20598,
            "en_name": "INFLUENZA VIRUS TYPE A",
            "fr_name": "Virus de l'Influenza de type A (H1N1)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32000000",
          "strength_unit": "FFU",
          "strength_type": "",
          "dosage_value": "0.2",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8354819,
          "ingredient": {
            "id": 3982,
            "ingredient_code": 22409,
            "en_name": "INFLUENZA VIRUS TYPE B",
            "fr_name": "Virus de l'influenza de type B (Yamagata)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32000000",
          "strength_unit": "FFU",
          "strength_type": "",
          "dosage_value": "0.2",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8354818,
          "ingredient": {
            "id": 3980,
            "ingredient_code": 22408,
            "en_name": "INFLUENZA VIRUS TYPE B",
            "fr_name": "Virus de l'influenza de type B (Victoria)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32000000",
          "strength_unit": "FFU",
          "strength_type": "",
          "dosage_value": "0.2",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02426544",
      "brand_name": "FLUMIST QUADRIVALENT",
      "brand_name_fr": "FLUMIST QUADRIVALENT",
      "descriptor": "0.2ML PREFILLED, SINGLE-USE GLASS SPRAYER",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0455811001"
    },
    "created_date": "2019-04-22T16:44:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426544",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "J07BB",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2019-10-01T00:00:00-04:00",
    "estimated_end_date": "2020-09-23T00:00:00-04:00",
    "actual_start_date": "2019-10-01T00:00:00-04:00",
    "actual_end_date": "2020-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-09-24T11:09:55-04:00",
    "status": "resolved",
    "en_comments": "Influenza vaccine for 2020-2021 season estimated availability September 23, 2020, in limited quantities",
    "fr_comments": "Influenza vaccine for 2020-2021 season estimated availability September 23, 2020, in limited quantities.",
    "en_drug_brand_name": "FLUMIST QUADRIVALENT",
    "en_drug_common_name": "Influenza vaccine (live, attenuated)",
    "fr_drug_brand_name": "Flumist Quadrivalent",
    "fr_drug_common_name": "Vaccin antigrippal (vivant, atténué)",
    "en_ingredients": "Influenza Virus Type A\r\nInfluenza Virus Type A\r\nInfluenza virus type B\r\nInfluenza virus type B",
    "fr_ingredients": "Virus de l'Influenza de type A\r\nVirus de l'Influenza de type A\r\nVirus de l'Influenza de type B\r\nVirus de l'Influenza de type B",
    "drug_strength": "32000000FFU\r\n32000000FFU\r\n32000000FFU\r\n32000000FFU",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "10 single use pre-filled syringes",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82182,
    "drug": {
      "current_status": "MARKETED",
      "id": 20698,
      "drug_code": 82485,
      "updated_date": "2025-05-15T02:32:33-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8257321,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02339242",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2019-04-23T01:17:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02339242",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2019-06-19T00:00:00-04:00",
    "actual_start_date": "2019-04-19T00:00:00-04:00",
    "actual_end_date": "2019-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-06-19T05:00:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR",
    "fr_drug_brand_name": "VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82201,
    "drug": {
      "current_status": "MARKETED",
      "id": 52181,
      "drug_code": 92868,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261353,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261352,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443902",
      "brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
      "brand_name_fr": "MYLAN-EMTRICITABINE/TÉNOFOVIR DISOPROXIL",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251568001"
    },
    "created_date": "2019-04-23T11:16:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443902",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2019-06-06T00:00:00-04:00",
    "estimated_end_date": "2019-07-30T00:00:00-04:00",
    "actual_start_date": "2019-06-11T00:00:00-04:00",
    "actual_end_date": "2019-06-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-06-26T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "en_drug_common_name": "EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "fr_drug_brand_name": "MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "fr_drug_common_name": "EMTRICITABINE/TENOFOVIR DISOPROXIL",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE\r\nEMTRICITABINE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil\r\nEmtricitabine",
    "drug_strength": "300MG\r\n200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82204,
    "drug": {
      "current_status": "MARKETED",
      "id": 14100,
      "drug_code": 74133,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255091,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256096",
      "brand_name": "MYLAN-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2019-04-23T11:43:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256096",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2019-04-26T00:00:00-04:00",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-05-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82221,
    "drug": {
      "current_status": "MARKETED",
      "id": 11812,
      "drug_code": 69385,
      "updated_date": "2025-12-03T00:30:49-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254383,
          "ingredient": {
            "id": 2508,
            "ingredient_code": 7485,
            "en_name": "TESTOSTERONE",
            "fr_name": "Testostérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245346",
      "brand_name": "ANDROGEL",
      "brand_name_fr": "",
      "descriptor": "5 G GEL PER PACK",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106405004"
    },
    "created_date": "2019-04-23T12:24:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245346",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "G03BA",
    "atc_description": "ANDROGENS",
    "anticipated_start_date": "2019-06-03T00:00:00-04:00",
    "estimated_end_date": "2019-06-15T00:00:00-04:00",
    "actual_end_date": "2019-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-05-28T15:30:59-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ANDROGEL",
    "en_drug_common_name": "TESTOSTERONE",
    "fr_drug_brand_name": "ANDROGEL",
    "fr_drug_common_name": "TESTOSTERONE",
    "en_ingredients": "TESTOSTERONE",
    "fr_ingredients": "Testostérone",
    "drug_strength": "1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82236,
    "drug": {
      "current_status": "MARKETED",
      "id": 30298,
      "drug_code": 92355,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 1770,
        "created_date": "2017-03-09T13:25:40-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 15633,
        "mfr_code": "",
        "name": "NATCO PHARMA (CANADA) INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2000 ARGENTIA ROAD, PLAZA 1, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261068,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439174",
      "brand_name": "NAT-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858004"
    },
    "created_date": "2019-04-23T15:37:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439174",
    "company_name": "NATCO PHARMA (CANADA) INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2019-04-23T00:00:00-04:00",
    "actual_start_date": "2019-04-23T00:00:00-04:00",
    "actual_end_date": "2021-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-10-31T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NAT-QUETIAPINE",
    "en_drug_common_name": "Quetiapine Fumarate",
    "fr_drug_brand_name": "NAT-Quetiapine",
    "fr_drug_common_name": "Quetiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine 150mg",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82271,
    "drug": {
      "current_status": "MARKETED",
      "id": 3036,
      "drug_code": 17752,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252208,
          "ingredient": {
            "id": 1334,
            "ingredient_code": 4028,
            "en_name": "SODIUM POLYSTYRENE SULFONATE",
            "fr_name": "Polystyrène sulfonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02026961",
      "brand_name": "KAYEXALATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79954",
      "number_of_ais": "1",
      "ai_group_no": "0108701006"
    },
    "created_date": "2019-04-23T19:32:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02026961",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "V03AE",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2019-04-26T00:00:00-04:00",
    "estimated_end_date": "2019-08-30T00:00:00-04:00",
    "actual_end_date": "2019-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-05-24T14:04:58-04:00",
    "status": "resolved",
    "en_comments": "Production delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy",
    "fr_comments": "Delai de production. La date de disponibilité est la date de disponibilité estimée au niveau du centre de distribution principal de Sanofi. La date de disponibilité au niveau du centre de distribution du grossiste habituel d’un client peut varier. Les pharmacies sont invitées à communiquer directement avec leur grossiste pour avoir une date de disponibilité pour le produit. Les patients sont invités à communiquer directement avec leur pharmacie pour obtenir plus de détails à propos de la disponibilité du produit.",
    "en_drug_brand_name": "KAYEXALATE",
    "en_drug_common_name": "Kayexalate",
    "fr_drug_brand_name": "KAYEXALATE",
    "fr_drug_common_name": "Kayexalate",
    "en_ingredients": "SODIUM POLYSTYRENE SULFONATE",
    "fr_ingredients": "Polystyrène sulfonate de sodium",
    "drug_strength": "100%",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "ORAL\r\nRECTAL",
    "drug_route_fr": "Orale\r\nRectale",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82303,
    "drug": {
      "current_status": "MARKETED",
      "id": 30404,
      "drug_code": 92456,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261109,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8261108,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02440180",
      "brand_name": "TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561001"
    },
    "created_date": "2019-04-24T14:23:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440180",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2019-09-13T00:00:00-04:00",
    "actual_start_date": "2019-04-17T00:00:00-04:00",
    "actual_end_date": "2019-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-09-04T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL",
    "en_drug_common_name": "TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL",
    "fr_drug_brand_name": "TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL",
    "fr_drug_common_name": "TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL",
    "en_ingredients": "BENZOYL PEROXIDE\r\nCLINDAMYCIN",
    "fr_ingredients": "Peroxyde de benzoyle",
    "drug_strength": "5%\r\n1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "45g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82318,
    "drug": {
      "current_status": "MARKETED",
      "id": 18354,
      "drug_code": 79616,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256436,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310546",
      "brand_name": "TARO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858002"
    },
    "created_date": "2019-04-24T14:51:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310546",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2019-04-26T00:00:00-04:00",
    "actual_start_date": "2019-04-15T00:00:00-04:00",
    "actual_end_date": "2019-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-29T14:39:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-RAMIPRIL",
    "en_drug_common_name": "RAN-RAMIPRIL",
    "fr_drug_brand_name": "RAN-RAMIPRIL",
    "fr_drug_common_name": "RAN-RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82331,
    "drug": {
      "current_status": "MARKETED",
      "id": 11196,
      "drug_code": 67530,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254205,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243611",
      "brand_name": "APO-ALPRAZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008003"
    },
    "created_date": "2019-04-24T15:59:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243611",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2019-08-01T00:00:00-04:00",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-02T21:09:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALPRAZ",
    "en_drug_common_name": "ALPRAZ",
    "fr_drug_brand_name": "APO-ALPRAZ",
    "fr_drug_common_name": "ALPRAZ",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82334,
    "drug": {
      "current_status": "MARKETED",
      "id": 9048,
      "drug_code": 61676,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253562,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238280",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2019-04-24T16:02:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238280",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2019-05-30T00:00:00-04:00",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-31T21:42:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82337,
    "drug": {
      "current_status": "MARKETED",
      "id": 22344,
      "drug_code": 84741,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257998,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362406",
      "brand_name": "APO-TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED-RELEASE TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2019-04-24T16:04:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362406",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2019-06-14T00:00:00-04:00",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-21T21:28:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN CR",
    "fr_drug_brand_name": "APO-TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN CR",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82340,
    "drug": {
      "current_status": "MARKETED",
      "id": 15782,
      "drug_code": 76522,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255649,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279614",
      "brand_name": "APO-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938001"
    },
    "created_date": "2019-04-24T16:05:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279614",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2019-07-26T00:00:00-04:00",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-19T21:10:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "APO-TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82343,
    "drug": {
      "current_status": "MARKETED",
      "id": 1894,
      "drug_code": 14031,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251852,
          "ingredient": {
            "id": 888,
            "ingredient_code": 231,
            "en_name": "THEOPHYLLINE",
            "fr_name": "Théophylline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00692700",
      "brand_name": "AA-THEO LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75533",
      "number_of_ais": "1",
      "ai_group_no": "0103582004"
    },
    "created_date": "2019-04-24T16:08:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00692700",
    "company_name": "APOTEX INC",
    "atc_number": "R03DA",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-08-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-14T13:33:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-THEO LA",
    "en_drug_common_name": "THEO LA",
    "fr_drug_brand_name": "APO-THEO LA",
    "fr_drug_common_name": "THEO LA",
    "en_ingredients": "THEOPHYLLINE",
    "fr_ingredients": "Théophylline",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82348,
    "drug": {
      "current_status": "MARKETED",
      "id": 27836,
      "drug_code": 90041,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260118,
          "ingredient": {
            "id": 2776,
            "ingredient_code": 11980,
            "en_name": "LEFLUNOMIDE",
            "fr_name": "Léflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415828",
      "brand_name": "PRO-LEFLUNOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140182001"
    },
    "created_date": "2019-04-24T17:00:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415828",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "actual_start_date": "2019-04-24T00:00:00-04:00",
    "actual_end_date": "2019-06-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-06-14T16:18:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEFLUNOMIDE",
    "en_drug_common_name": "LEFLUNOMIDE",
    "fr_drug_brand_name": "LEFLUNOMIDE",
    "fr_drug_common_name": "LEFLUNOMIDE",
    "en_ingredients": "LEFLUNOMIDE",
    "fr_ingredients": "Léflunomide",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82366,
    "drug": {
      "current_status": "MARKETED",
      "id": 28888,
      "drug_code": 90986,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260495,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02425211",
      "brand_name": "BIO-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2019-04-24T17:37:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02425211",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-06-30T00:00:00-04:00",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-06-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIO-EZETIMIBE",
    "en_drug_common_name": "EZETIMIBE",
    "fr_drug_brand_name": "BIO",
    "fr_drug_common_name": "EZETIMIBE",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3x10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82373,
    "drug": {
      "current_status": "MARKETED",
      "id": 30934,
      "drug_code": 93070,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261424,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02446286",
      "brand_name": "BIO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2019-04-24T17:44:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446286",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2019-04-20T00:00:00-04:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-01T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIO-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "BIO",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82376,
    "drug": {
      "id": 30886,
      "drug_code": 93021,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261412,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444992",
      "brand_name": "BIO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2019-04-24T17:47:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444992",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2019-04-21T00:00:00-04:00",
    "actual_end_date": "2019-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-09-25T15:14:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "BIO",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATINE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82386,
    "drug": {
      "current_status": "MARKETED",
      "id": 6510,
      "drug_code": 43431,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253083,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02225883",
      "brand_name": "PROPRANOLOL HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9769",
      "number_of_ais": "1",
      "ai_group_no": "0101831007"
    },
    "created_date": "2019-04-24T20:48:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02225883",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2019-07-12T00:00:00-04:00",
    "estimated_end_date": "2019-07-26T00:00:00-04:00",
    "actual_end_date": "2019-08-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-09-25T12:37:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PROPRANOLOL HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "PROPRANOLOL",
    "fr_drug_brand_name": "PROPRANOLOL",
    "fr_drug_common_name": "PROPRANOLOL",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 X 1ML VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82410,
    "drug": {
      "current_status": "MARKETED",
      "id": 30366,
      "drug_code": 9242,
      "updated_date": "2025-12-03T00:30:26-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251137,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00782718",
      "brand_name": "TEVA-CARBAMAZEPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68169",
      "number_of_ais": "1",
      "ai_group_no": "0108674001"
    },
    "created_date": "2019-04-25T15:38:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00782718",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AF",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2019-05-15T00:00:00-04:00",
    "actual_start_date": "2019-04-25T00:00:00-04:00",
    "actual_end_date": "2019-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-28T14:14:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CARBAMAZEPINE",
    "en_drug_common_name": "CARBAMAZEPINE",
    "fr_drug_brand_name": "TEVA-CARBAMAZEPINE",
    "fr_drug_common_name": "CARBAMAZEPINE",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82413,
    "drug": {
      "current_status": "MARKETED",
      "id": 24856,
      "drug_code": 87386,
      "updated_date": "2025-05-15T02:33:33-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258990,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258989,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388324",
      "brand_name": "MAR-TRAMADOL/ACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2019-04-25T15:39:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388324",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2019-07-10T00:00:00-04:00",
    "actual_start_date": "2019-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-01-30T13:59:45-05:00",
    "status": "active_confirmed",
    "en_comments": "SKU issue, we have enough inventory for 100 packs, not enough of the 60 Blisters.",
    "fr_comments": "SKU issue. We have enough inventory for 100s bottles, but inventory is low in the 60s blisters.",
    "en_drug_brand_name": "MAR-TRAMADOL/ACET",
    "en_drug_common_name": "TRAMADOL/ACET",
    "fr_drug_brand_name": "MAR-TRAMADOL/ACET",
    "fr_drug_common_name": "TRAMADOL/ACET",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de tramadol\r\nAcétaminophène",
    "drug_strength": "37.5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 tablets",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82422,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23848,
      "drug_code": 86514,
      "updated_date": "2025-05-15T04:19:49-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8351201,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379260",
      "brand_name": "ACH-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220001"
    },
    "created_date": "2019-04-25T16:54:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379260",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2019-04-25T00:00:00-04:00",
    "actual_start_date": "2019-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-10-14T15:57:25-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-CANDESARTAN",
    "en_drug_common_name": "ACH-Candesartan",
    "fr_drug_brand_name": "ACH-Candesartan",
    "fr_drug_common_name": "ACH-Candesartan",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82426,
    "drug": {
      "current_status": "MARKETED",
      "id": 13404,
      "drug_code": 73070,
      "updated_date": "2025-05-15T02:31:32-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8254866,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248706",
      "brand_name": "PRO-ALPRAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008003"
    },
    "created_date": "2019-04-25T17:04:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248706",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2019-08-26T00:00:00-04:00",
    "actual_start_date": "2019-04-25T00:00:00-04:00",
    "actual_end_date": "2019-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-08-22T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALPRAZOLAM",
    "en_drug_common_name": "ALPRAZOLAM",
    "fr_drug_brand_name": "ALPRAZOLAM",
    "fr_drug_common_name": "ALPRAZOLAM",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82477,
    "drug": {
      "current_status": "MARKETED",
      "id": 28508,
      "drug_code": 90628,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260344,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02421631",
      "brand_name": "NIFEDIPINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253004"
    },
    "created_date": "2019-04-26T15:12:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421631",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "actual_start_date": "2019-05-06T00:00:00-04:00",
    "actual_end_date": "2019-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-06-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NIFEDIPINE ER",
    "en_drug_common_name": "NIFEDIPINE ER",
    "fr_drug_brand_name": "NIFEDIPINE ER",
    "fr_drug_common_name": "NIFEDIPINE ER",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82479,
    "drug": {
      "current_status": "MARKETED",
      "id": 21920,
      "drug_code": 84276,
      "updated_date": "2025-05-15T02:32:49-04:00",
      "company": {
        "id": 1020,
        "created_date": "2017-03-09T13:23:37-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 13175,
        "mfr_code": "",
        "name": "UCB CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "602",
        "street_name": "2201 BRISTOL CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0J8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257842,
          "ingredient": {
            "id": 3686,
            "ingredient_code": 20636,
            "en_name": "LACOSAMIDE",
            "fr_name": "Lacosamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02357666",
      "brand_name": "VIMPAT",
      "brand_name_fr": "",
      "descriptor": "20ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152810005"
    },
    "created_date": "2019-04-26T15:12:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02357666",
    "company_name": "UCB CANADA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2019-05-15T00:00:00-04:00",
    "estimated_end_date": "2019-06-17T00:00:00-04:00",
    "actual_start_date": "2019-05-20T00:00:00-04:00",
    "actual_end_date": "2019-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-06-26T17:50:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VIMPAT",
    "en_drug_common_name": "VIMPAT IV 10mg/mL",
    "fr_drug_brand_name": "VIMPAT",
    "fr_drug_common_name": "VIMPAT IV 10mg/mL",
    "en_ingredients": "LACOSAMIDE",
    "fr_ingredients": "Lacosamide",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 x 20mL vials/carton",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82497,
    "drug": {
      "current_status": "MARKETED",
      "id": 12334,
      "drug_code": 70751,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8254544,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254543,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246568",
      "brand_name": "COVERSYL PLUS LD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401002"
    },
    "created_date": "2019-04-26T15:35:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246568",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2019-05-03T00:00:00-04:00",
    "actual_start_date": "2019-04-23T00:00:00-04:00",
    "actual_end_date": "2019-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-03T15:26:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COVERSYL PLUS LD",
    "en_drug_common_name": "COVERSYL PLUS LD",
    "fr_drug_brand_name": "Coversyl Plus LD",
    "fr_drug_common_name": "Coversyl Plus LD",
    "en_ingredients": "INDAPAMIDE\r\nPERINDOPRIL ERBUMINE",
    "fr_ingredients": "Indapamide\r\nPérindopril erbumine",
    "drug_strength": "0.625MG\r\n2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82512,
    "drug": {
      "current_status": "DORMANT",
      "id": 23170,
      "drug_code": 85748,
      "updated_date": "2025-12-03T02:32:29-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368679,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02372347",
      "brand_name": "IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2019-04-26T16:37:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02372347",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2019-05-10T00:00:00-04:00",
    "estimated_end_date": "2019-05-31T00:00:00-04:00",
    "actual_start_date": "2019-05-10T00:00:00-04:00",
    "actual_end_date": "2019-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-04T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82527,
    "drug": {
      "current_status": "MARKETED",
      "id": 23014,
      "drug_code": 85592,
      "updated_date": "2025-05-15T02:32:59-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258319,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370808",
      "brand_name": "PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2019-04-26T16:46:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370808",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-03-31T00:00:00-04:00",
    "actual_start_date": "2019-04-26T00:00:00-04:00",
    "actual_end_date": "2020-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-03-04T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPROZOLE",
    "fr_drug_brand_name": "PANTOPROZOLE",
    "fr_drug_common_name": "PANTOPROZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPROZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82552,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22998,
      "drug_code": 85575,
      "updated_date": "2025-12-03T01:29:15-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350462,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370611",
      "brand_name": "ACT DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863004"
    },
    "created_date": "2019-04-26T17:22:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370611",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2021-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-26T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "ACT Item is discontinued, TEVA DIN is now available.",
    "fr_comments": "ACT Item is discontinued, TEVA DIN is now available.",
    "en_drug_brand_name": "ACT DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "ACT-DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82555,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23000,
      "drug_code": 85576,
      "updated_date": "2025-12-03T01:29:15-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350463,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370638",
      "brand_name": "ACT DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2019-04-26T17:24:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370638",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "actual_start_date": "2019-04-01T00:00:00-04:00",
    "actual_end_date": "2021-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-26T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "ACT Item is discontinued, TEVA DIN is now available.",
    "fr_comments": "ACT Item is discontinued, TEVA DIN is now available.",
    "en_drug_brand_name": "ACT DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "ACT DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82566,
    "drug": {
      "current_status": "MARKETED",
      "id": 31606,
      "drug_code": 93924,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261833,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452839",
      "brand_name": "AURO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2019-04-26T18:00:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452839",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2019-04-26T00:00:00-04:00",
    "actual_end_date": "2019-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-06-24T17:31:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine",
    "fr_drug_brand_name": "AURO-VENLAFAXINE XR",
    "fr_drug_common_name": "Venlafaxine",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 & 500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82569,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12914,
      "drug_code": 72083,
      "updated_date": "2025-05-15T04:07:26-04:00",
      "company": {
        "id": 318,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4174,
        "mfr_code": "FEI08",
        "name": "FERRING INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "500",
        "street_name": "200 YORKLAND BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2J 5C1",
        "post_office_box": "",
        "contact_information": "1-800-263-4057"
      },
      "drug_ingredients": [
        {
          "id": 8338519,
          "ingredient": {
            "id": 3062,
            "ingredient_code": 7369,
            "en_name": "MENOTROPINS",
            "fr_name": "Ménotropines"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02247790",
      "brand_name": "REPRONEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149345001"
    },
    "created_date": "2019-04-26T19:08:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247790",
    "company_name": "FERRING INC",
    "atc_number": "G03GA",
    "atc_description": "GONADOTROPHINS AND OTHER OVULATION STIMULANTS",
    "discontinuation_date": "2019-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "REPRONEX is discontinued.  Alternate products are available by Ferring such as MENOPUR (Menotropins for injection) (75 IU FSH/ 75 IU LH).  Please contact your healthcare professional.",
    "fr_discontinuation_comments": "Le produit est abandonné.\r\n\r\nDes produits de remplacement sont disponibles chez Ferring, tels que les Gonadotrophines humaines pour injection, (Poudre pour solution) MENOPUR (75 UI d'hormone folliculo-stimulante / 75 UI d'hormone lutéinisante).\r\n\r\nVeuillez contacter votre professionnel de la santé.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-27T14:40:17-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "REPRONEX",
    "en_drug_common_name": "Menotropins for Injection",
    "fr_drug_brand_name": "REPRONEX",
    "fr_drug_common_name": "Gonadotrophines humaines pour injection",
    "en_ingredients": "MENOTROPINS",
    "fr_ingredients": "Ménotropines",
    "drug_strength": "75UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nSous-cutanée",
    "drug_package_quantity": "Boxes 5 vials + 5x2 mL vials diluent",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82597,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28720,
      "drug_code": 90845,
      "updated_date": "2025-05-15T04:22:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8354577,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423758",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "5MG/5ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935002"
    },
    "created_date": "2019-04-29T13:23:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423758",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2019-09-20T00:00:00-04:00",
    "actual_end_date": "2019-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-10-22T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10 x 5mL AMP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82602,
    "drug": {
      "current_status": "MARKETED",
      "id": 55375,
      "drug_code": 94943,
      "updated_date": "2025-12-03T00:33:20-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262357,
          "ingredient": {
            "id": 12458,
            "ingredient_code": 22953,
            "en_name": "IMMUNOGLOBULIN",
            "fr_name": "Immunoglobuline (humaine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02461692",
      "brand_name": "CUVITRU",
      "brand_name_fr": "",
      "descriptor": "NORMAL IMMUNE GLOBULIN (HUMAN). SINGLE-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106267011"
    },
    "created_date": "2019-04-29T13:46:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461692",
    "company_name": "SHIRE PHARMA CANADA ULC",
    "atc_number": "J06BA",
    "atc_description": "IMMUNOGLOBULINS",
    "anticipated_start_date": "2019-04-09T00:00:00-04:00",
    "estimated_end_date": "2019-09-30T00:00:00-04:00",
    "actual_start_date": "2019-05-09T00:00:00-04:00",
    "actual_end_date": "2019-08-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-08-24T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Shortage resolved on 2019-08-23",
    "fr_comments": "Pénurie résolue le 23Août2019",
    "en_drug_brand_name": "CUVITRU",
    "en_drug_common_name": "Immune globulin Subcutaneous 20%",
    "fr_drug_brand_name": "Cuvitru",
    "fr_drug_common_name": "ImmunoGlobuline sous-cutanee 20%",
    "en_ingredients": "IMMUNOGLOBULIN",
    "fr_ingredients": "Immunoglobuline",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "1g, 2g,4g and 8g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82607,
    "drug": {
      "current_status": "MARKETED",
      "id": 10902,
      "drug_code": 66824,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254108,
          "ingredient": {
            "id": 2848,
            "ingredient_code": 7509,
            "en_name": "HYDROCORTISONE VALERATE",
            "fr_name": "Valérate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242984",
      "brand_name": "HYDROVAL CREAM 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112513001"
    },
    "created_date": "2019-04-29T14:26:45-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242984",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2019-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinuation of 15 g pack size ONLY.  Other sizes continue to be available.",
    "fr_discontinuation_comments": "Discontinuation de 15g SEULEMENT. D'autres tailles restent disponibles",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-29T14:28:14-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "en_drug_common_name": "HYDROVAL CREAM 0.2%",
    "fr_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "fr_drug_common_name": "HYDROVAL CREAM 0.2%",
    "en_ingredients": "HYDROCORTISONE VALERATE",
    "fr_ingredients": "Valérate d'hydrocortisone",
    "drug_strength": "0.2%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82611,
    "drug": {
      "current_status": "MARKETED",
      "id": 10904,
      "drug_code": 66825,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254109,
          "ingredient": {
            "id": 2848,
            "ingredient_code": 7509,
            "en_name": "HYDROCORTISONE VALERATE",
            "fr_name": "Valérate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242985",
      "brand_name": "HYDROVAL OINTMENT 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112513001"
    },
    "created_date": "2019-04-29T14:30:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242985",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2019-05-10T00:00:00-04:00",
    "actual_start_date": "2019-04-16T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-13T15:48:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROVAL OINTMENT 0.2%",
    "en_drug_common_name": "HYDROVAL OINTMENT 0.2%",
    "fr_drug_brand_name": "HYDROVAL OINTMENT 0.2%",
    "fr_drug_common_name": "HYDROVAL OINTMENT 0.2%",
    "en_ingredients": "HYDROCORTISONE VALERATE",
    "fr_ingredients": "Valérate d'hydrocortisone",
    "drug_strength": "0.2%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82626,
    "drug": {
      "current_status": "MARKETED",
      "id": 15820,
      "drug_code": 76560,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255666,
          "ingredient": {
            "id": 1124,
            "ingredient_code": 1832,
            "en_name": "MUPIROCIN",
            "fr_name": "Mupirocine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279983",
      "brand_name": "TARO-MUPIROCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117081001"
    },
    "created_date": "2019-04-29T14:35:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279983",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D06AX",
    "atc_description": "ANTIBIOTICS FOR TOPICAL USE",
    "estimated_end_date": "2019-07-19T00:00:00-04:00",
    "actual_start_date": "2019-04-25T00:00:00-04:00",
    "actual_end_date": "2019-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-MUPIROCIN",
    "en_drug_common_name": "TARO-MUPIROCIN",
    "fr_drug_brand_name": "TARO-MUPIROCIN",
    "fr_drug_common_name": "TARO-MUPIROCIN",
    "en_ingredients": "MUPIROCIN",
    "fr_ingredients": "Mupirocine",
    "drug_strength": "2%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "30 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82629,
    "drug": {
      "current_status": "MARKETED",
      "id": 27758,
      "drug_code": 89980,
      "updated_date": "2025-05-15T02:34:05-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260068,
          "ingredient": {
            "id": 3086,
            "ingredient_code": 12024,
            "en_name": "ZOLEDRONIC ACID",
            "fr_name": "Acide zolédronique (Acide zolédronique monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02415186",
      "brand_name": "TARO-ZOLEDRONIC ACID CONCENTRATE",
      "brand_name_fr": "",
      "descriptor": "TO BE DILUTED BEFORE USE. FOR IV INFUSION. 5ML SINGLE DOSE VIAL.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141761002"
    },
    "created_date": "2019-04-29T14:36:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415186",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2019-06-28T00:00:00-04:00",
    "actual_start_date": "2019-04-26T00:00:00-04:00",
    "actual_end_date": "2019-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-08T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-ZOLEDRONIC ACID CONCENTRATE",
    "en_drug_common_name": "TARO-ZOLEDRONIC ACID CONCENTRATE",
    "fr_drug_brand_name": "TARO-ZOLEDRONIC ACID CONCENTRATE",
    "fr_drug_common_name": "TARO-ZOLEDRONIC ACID CONCENTRATE",
    "en_ingredients": "ZOLEDRONIC ACID",
    "fr_ingredients": "Zoledronic Acid",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82648,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27468,
      "drug_code": 89701,
      "updated_date": "2025-12-03T01:31:34-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8353602,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02412381",
      "brand_name": "TARO-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043002"
    },
    "created_date": "2019-04-29T14:44:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02412381",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2019-07-05T00:00:00-04:00",
    "actual_start_date": "2019-04-24T00:00:00-04:00",
    "actual_end_date": "2019-07-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-06T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-CELECOXIB",
    "en_drug_common_name": "RAN-CELECOXIB",
    "fr_drug_brand_name": "RAN-CELECOXIB",
    "fr_drug_common_name": "RAN-CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82651,
    "drug": {
      "current_status": "MARKETED",
      "id": 22234,
      "drug_code": 84648,
      "updated_date": "2025-12-03T00:31:43-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257956,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361426",
      "brand_name": "TARO-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752001"
    },
    "created_date": "2019-04-29T14:45:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361426",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2019-05-10T00:00:00-04:00",
    "actual_start_date": "2019-04-26T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-13T15:32:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-CLARITHROMYCIN",
    "en_drug_common_name": "RAN-CLARITHROMYCIN",
    "fr_drug_brand_name": "RAN-CLARITHROMYCIN",
    "fr_drug_common_name": "RAN-CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82654,
    "drug": {
      "current_status": "MARKETED",
      "id": 20084,
      "drug_code": 81484,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257080,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02329158",
      "brand_name": "TARO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2019-04-29T14:46:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329158",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-07-31T00:00:00-04:00",
    "actual_start_date": "2019-04-26T00:00:00-04:00",
    "actual_end_date": "2019-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-06T13:17:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-SIMVASTATIN",
    "en_drug_common_name": "RAN-SIMVASTATIN",
    "fr_drug_brand_name": "RAN-SIMVASTATIN",
    "fr_drug_common_name": "RAN-SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82665,
    "drug": {
      "current_status": "MARKETED",
      "id": 24236,
      "drug_code": 86848,
      "updated_date": "2025-12-03T00:31:56-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258721,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382660",
      "brand_name": "TARO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2019-04-29T14:49:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382660",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-05-10T00:00:00-04:00",
    "actual_start_date": "2019-04-22T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-13T15:30:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SUNPHARMA ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "SUNPHARMA-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82678,
    "drug": {
      "current_status": "MARKETED",
      "id": 19250,
      "drug_code": 80508,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8256730,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256729,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02319616",
      "brand_name": "OLMETEC PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502001"
    },
    "created_date": "2019-04-29T15:19:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319616",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2019-05-20T00:00:00-04:00",
    "estimated_end_date": "2019-08-02T00:00:00-04:00",
    "actual_start_date": "2019-05-07T00:00:00-04:00",
    "actual_end_date": "2019-08-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-08-03T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OLMETEC PLUS",
    "en_drug_common_name": "Olmesartan medoxomil and hydrochlorothiazide tablets",
    "fr_drug_brand_name": "OLMETEC PLUS",
    "fr_drug_common_name": "comprimés d'olmésartan médoxomil et hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 Tab",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82695,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19710,
      "drug_code": 81071,
      "updated_date": "2025-05-15T04:14:37-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346996,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325314",
      "brand_name": "DILTIAZEM TZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2019-04-29T17:50:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325314",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "hc_updated_date": "2021-08-06T19:02:40-04:00",
    "actual_start_date": "2019-05-23T00:00:00-04:00",
    "actual_end_date": "2021-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-08-06T19:02:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DILTIAZEM TZ",
    "en_drug_common_name": "DILTIAZEM TZ",
    "fr_drug_brand_name": "DILTIAZEM TZ",
    "fr_drug_common_name": "DILTIAZEM TZ",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82698,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19714,
      "drug_code": 81073,
      "updated_date": "2025-05-15T04:14:37-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346998,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325330",
      "brand_name": "DILTIAZEM TZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863008"
    },
    "created_date": "2019-04-29T17:52:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325330",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "hc_updated_date": "2021-08-06T19:04:26-04:00",
    "anticipated_start_date": "2019-08-05T00:00:00-04:00",
    "actual_start_date": "2019-08-01T00:00:00-04:00",
    "actual_end_date": "2021-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-08-06T19:04:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DILTIAZEM TZ",
    "en_drug_common_name": "DILTIAZEM TZ",
    "fr_drug_brand_name": "DILTIAZEM TZ",
    "fr_drug_common_name": "DILTIAZEM TZ",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82729,
    "drug": {
      "current_status": "MARKETED",
      "id": 17130,
      "drug_code": 78165,
      "updated_date": "2025-05-15T02:31:57-04:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256043,
          "ingredient": {
            "id": 3400,
            "ingredient_code": 20141,
            "en_name": "IDURSULFASE",
            "fr_name": "Idursulfase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02296314",
      "brand_name": "ELAPRASE",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152221001"
    },
    "created_date": "2019-04-29T19:25:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02296314",
    "company_name": "SHIRE HUMAN GENETIC THERAPIES INC",
    "atc_number": "A16AB",
    "atc_description": "OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS",
    "anticipated_start_date": "2019-04-29T00:00:00-04:00",
    "estimated_end_date": "2019-05-02T00:00:00-04:00",
    "actual_start_date": "2019-04-29T00:00:00-04:00",
    "actual_end_date": "2019-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELAPRASE",
    "en_drug_common_name": "Idursulfase intravenous",
    "fr_drug_brand_name": "Elaprase",
    "fr_drug_common_name": "Idursulfase intraveineux",
    "en_ingredients": "IDURSULFASE",
    "fr_ingredients": "Idursulfase",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "2mg",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82741,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9536,
      "drug_code": 6311,
      "updated_date": "2025-05-15T03:29:43-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8280180,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00658855",
      "brand_name": "LOPRESOR SR 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62779",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2019-04-29T20:02:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00658855",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2019-08-16T00:00:00-04:00",
    "actual_start_date": "2019-04-25T00:00:00-04:00",
    "actual_end_date": "2019-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-08-12T19:21:07-04:00",
    "status": "resolved",
    "en_comments": "Disruption in supply of drug",
    "fr_comments": "Perturbation de l’approvisionnement du medicament",
    "en_drug_brand_name": "LOPRESOR SR 100MG",
    "en_drug_common_name": "LOPRESOR SR 100MG TABS 100'S",
    "fr_drug_brand_name": "LOPRESOR SR 100MG",
    "fr_drug_common_name": "LOPRESOR SR 100MG TABS 100'S",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82748,
    "drug": {
      "current_status": "MARKETED",
      "id": 11006,
      "drug_code": 67033,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254138,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8254137,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02243158",
      "brand_name": "CLINDOXYL GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561001"
    },
    "created_date": "2019-04-29T20:15:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243158",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2019-05-24T00:00:00-04:00",
    "actual_start_date": "2019-04-25T00:00:00-04:00",
    "actual_end_date": "2019-05-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-22T14:16:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDOXYL GEL",
    "en_drug_common_name": "clindamycin and benzoyl peroxide gel",
    "fr_drug_brand_name": "gel CLINDOXYL",
    "fr_drug_common_name": "gel de clindamycine et de peroxyde de benzoyle",
    "en_ingredients": "BENZOYL PEROXIDE\r\nCLINDAMYCIN",
    "fr_ingredients": "Peroxyde de benzoyle; Clindamycine (CLINDAMYCIN PHOSPHATE)",
    "drug_strength": "50MG\r\n10MG",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "45g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82753,
    "drug": {
      "current_status": "MARKETED",
      "id": 16774,
      "drug_code": 77733,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255929,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02291967",
      "brand_name": "APO-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120002"
    },
    "created_date": "2019-04-29T20:43:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02291967",
    "company_name": "AA PHARMA INC",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2019-05-27T00:00:00-04:00",
    "actual_start_date": "2019-04-29T00:00:00-04:00",
    "actual_end_date": "2019-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-22T14:08:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ONDANSETRON",
    "en_drug_common_name": "Ondansetron",
    "fr_drug_brand_name": "Ondansetron",
    "fr_drug_common_name": "Ondansetron",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82756,
    "drug": {
      "current_status": "MARKETED",
      "id": 13954,
      "drug_code": 7391,
      "updated_date": "2025-05-15T02:30:39-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251013,
          "ingredient": {
            "id": 1906,
            "ingredient_code": 8008,
            "en_name": "HYDROXYZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydroxyzine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00646016",
      "brand_name": "HYDROXYZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65325",
      "number_of_ais": "1",
      "ai_group_no": "0106172004"
    },
    "created_date": "2019-04-29T20:52:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00646016",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05BB",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2019-05-27T00:00:00-04:00",
    "actual_start_date": "2019-04-29T00:00:00-04:00",
    "actual_end_date": "2019-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-08-22T14:05:50-04:00",
    "status": "resolved",
    "en_comments": "Hydoxyzine 25 mg is available",
    "fr_comments": "Hydroxyzine 25 mg est disponible",
    "en_drug_brand_name": "HYDROXYZINE",
    "en_drug_common_name": "Hydoxyzine",
    "fr_drug_brand_name": "Hydroxyzine",
    "fr_drug_common_name": "Hydroxyzine",
    "en_ingredients": "HYDROXYZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydroxyzine",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82759,
    "drug": {
      "current_status": "MARKETED",
      "id": 14346,
      "drug_code": 74515,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255162,
          "ingredient": {
            "id": 2642,
            "ingredient_code": 11821,
            "en_name": "TIZANIDINE",
            "fr_name": "Tizanidine (Chlorhydrate de tizanidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02259893",
      "brand_name": "APO-TIZANIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135342001"
    },
    "created_date": "2019-04-29T20:54:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02259893",
    "company_name": "AA PHARMA INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "estimated_end_date": "2019-05-10T00:00:00-04:00",
    "actual_start_date": "2019-04-29T00:00:00-04:00",
    "actual_end_date": "2019-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-27T13:33:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TIZANIDINE",
    "en_drug_common_name": "Tizanidine",
    "fr_drug_brand_name": "Tizanidine",
    "fr_drug_common_name": "Tizanidine",
    "en_ingredients": "TIZANIDINE",
    "fr_ingredients": "Tizanidine HCl",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100MG",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82762,
    "drug": {
      "current_status": "MARKETED",
      "id": 9406,
      "drug_code": 62666,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253667,
          "ingredient": {
            "id": 1970,
            "ingredient_code": 7897,
            "en_name": "RUBELLA VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin antirubéoleux vivant atténué (souche wistar ra27/3)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253666,
          "ingredient": {
            "id": 1972,
            "ingredient_code": 7908,
            "en_name": "MEASLES VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin antirougeoleux, vivant, atténué"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253665,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "ML",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8253664,
          "ingredient": {
            "id": 1968,
            "ingredient_code": 11271,
            "en_name": "MUMPS VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin contre les oreillons vivant atténué (souche jeryl lynn)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02239208",
      "brand_name": "PRIORIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0431514004"
    },
    "created_date": "2019-04-29T20:56:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239208",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BD",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2019-07-12T00:00:00-04:00",
    "actual_start_date": "2019-04-24T00:00:00-04:00",
    "actual_end_date": "2019-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-07-13T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100.",
    "fr_comments": "Retard dans l’approvisionnement de diluant de GSK (emballages de 10) requis pour l’utilisation avec un vaccin. Stocks de rechange de diluant de GSK offerts en boîtes de 100.",
    "en_drug_brand_name": "PRIORIX",
    "en_drug_common_name": "Combined measles, mumps and rubella vaccine, live, attenuated",
    "fr_drug_brand_name": "PRIORIX",
    "fr_drug_common_name": "Vaccin associé rougeole-oreillons-rubéole à virus vivants, atténués",
    "en_ingredients": "MUMPS VIRUS VACCINE LIVE ATTENUATED\r\nRUBELLA VIRUS VACCINE LIVE ATTENUATED\r\nMEASLES VIRUS VACCINE LIVE ATTENUATED\r\nWATER",
    "fr_ingredients": "Vaccin antirougeoleux, vivant, atténué; \r\n\r\nVaccin contre les oreillons vivant atténué (souche jeryl lynn);  \r\n\r\nVaccin antirubéoleux vivant atténué (souche wistar ra27/3)",
    "drug_strength": "10000UNIT\r\n1000UNIT\r\n1000UNIT\r\n0.5ML",
    "drug_dosage_form": "KIT\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Trousse\r\nPoudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "10's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82764,
    "drug": {
      "current_status": "MARKETED",
      "id": 16634,
      "drug_code": 77563,
      "updated_date": "2025-12-03T00:31:11-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255901,
          "ingredient": {
            "id": 1058,
            "ingredient_code": 1215,
            "en_name": "BENAZEPRIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bénazépril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02290332",
      "brand_name": "BENAZEPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122438001"
    },
    "created_date": "2019-04-29T20:56:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02290332",
    "company_name": "AA PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-04-15T00:00:00-04:00",
    "actual_start_date": "2019-04-29T00:00:00-04:00",
    "actual_end_date": "2020-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-03-04T17:43:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BENAZEPRIL",
    "en_drug_common_name": "Benazepril",
    "fr_drug_brand_name": "Benazepril",
    "fr_drug_common_name": "Benazepril",
    "en_ingredients": "BENAZEPRIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bénazépril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82768,
    "drug": {
      "current_status": "MARKETED",
      "id": 17268,
      "drug_code": 78322,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8256095,
          "ingredient": {
            "id": 35968,
            "ingredient_code": 23453,
            "en_name": "VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin contre le virus de la varicelle et zona vivant, atténué (souche Oka)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1995.2623",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8256094,
          "ingredient": {
            "id": 1968,
            "ingredient_code": 11271,
            "en_name": "MUMPS VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin contre les oreillons vivant atténué (souche jeryl lynn)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25118.9",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8256093,
          "ingredient": {
            "id": 1970,
            "ingredient_code": 7897,
            "en_name": "RUBELLA VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin antirubéoleux vivant atténué (souche wistar ra27/3)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8256092,
          "ingredient": {
            "id": 1972,
            "ingredient_code": 7908,
            "en_name": "MEASLES VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin antirougeoleux, vivant, atténué"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "CCID50",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02297884",
      "brand_name": "PRIORIX-TETRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0464901001"
    },
    "created_date": "2019-04-29T21:03:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297884",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BD",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2019-07-12T00:00:00-04:00",
    "actual_start_date": "2019-04-24T00:00:00-04:00",
    "actual_end_date": "2019-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-07-13T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100.",
    "fr_comments": "Retard dans l’approvisionnement de diluant de GSK (emballages de 10) requis pour l’utilisation avec un vaccin. Stocks de rechange de diluant de GSK offerts en boîtes de 100.",
    "en_drug_brand_name": "PRIORIX-TETRA",
    "en_drug_common_name": "Combined measles, mumps, rubella and varicella vaccine, live, attenuated",
    "fr_drug_brand_name": "PRIORIX-TETRA",
    "fr_drug_common_name": "Vaccin associé rougeole-oreillons-rubéole-varicelle à virus vivants, atténués",
    "en_ingredients": "MUMPS VIRUS VACCINE LIVE ATTENUATED\r\nVARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED\r\nRUBELLA VIRUS VACCINE LIVE ATTENUATED\r\nMEASLES VIRUS VACCINE LIVE ATTENUATED",
    "fr_ingredients": "Vaccin antirougeoleux, vivant, atténué; \r\n\r\nVaccin contre les oreillons vivant atténué (souche jeryl lynn);  \r\n  \r\nVaccin antirubéoleux vivant atténué (souche wistar ra27/3); \r\n\r\nVaccin contre le virus varicelle-zona vivant atténué (souche Oka/Merck)",
    "drug_strength": "25118.9UNIT\r\n1995.2623UNIT\r\n1000UNIT\r\n1000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nSous-cutanée",
    "drug_package_quantity": "10's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82771,
    "drug": {
      "current_status": "MARKETED",
      "id": 10066,
      "drug_code": 64641,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253827,
          "ingredient": {
            "id": 35968,
            "ingredient_code": 23453,
            "en_name": "VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin contre le virus de la varicelle et zona vivant, atténué (souche Oka)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1995",
          "strength_unit": "PFU",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253826,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "ML",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241047",
      "brand_name": "VARILRIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0262214002"
    },
    "created_date": "2019-04-29T21:07:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241047",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BK",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2019-07-12T00:00:00-04:00",
    "actual_start_date": "2019-04-24T00:00:00-04:00",
    "actual_end_date": "2019-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-07-13T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100.",
    "fr_comments": "Retard dans l’approvisionnement de diluant de GSK (emballages de 10) requis pour l’utilisation avec un vaccin. Stocks de rechange de diluant de GSK offerts en boîtes de 100.",
    "en_drug_brand_name": "VARILRIX",
    "en_drug_common_name": "Varicella virus vaccine, live, attenuated (Oka-strain)",
    "fr_drug_brand_name": "VARILRIX",
    "fr_drug_common_name": "Vaccin contre la varicelle, à virus vivant, atténué (souche Oka)",
    "en_ingredients": "WATER\r\nVARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED",
    "fr_ingredients": "Vaccin contre le virus varicelle-zona vivant atténué (souche Oka/Merck)",
    "drug_strength": "0.5ML\r\n2000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "10's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82804,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28722,
      "drug_code": 90846,
      "updated_date": "2025-05-15T04:22:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8354578,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423766",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "5MG/ML; 15MG/3ML; 50MG/10ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2019-04-30T14:02:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423766",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2019-05-03T00:00:00-04:00",
    "actual_end_date": "2019-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-06-06T12:50:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10 x 1mL AMP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82807,
    "drug": {
      "current_status": "MARKETED",
      "id": 21144,
      "drug_code": 8352,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251080,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00710814",
      "brand_name": "EPINEPHRINE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66766",
      "number_of_ais": "1",
      "ai_group_no": "0104871003"
    },
    "created_date": "2019-04-30T14:06:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00710814",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "actual_start_date": "2019-04-30T00:00:00-04:00",
    "actual_end_date": "2019-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-29T16:43:42-04:00",
    "status": "resolved",
    "en_comments": "Current inventory is on preventative allocation.",
    "fr_comments": "L'inventaire est sous allocation préventive.",
    "en_drug_brand_name": "EPINEPHRINE INJECTION USP",
    "en_drug_common_name": "Epinephrine Injection USP",
    "fr_drug_brand_name": "Epinephrine Injection USP",
    "fr_drug_common_name": "Epinephrine Injection USP",
    "en_ingredients": "EPINEPHRINE",
    "fr_ingredients": "Épinéphrine",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRACARDIAC\r\nINTRAVENOUS",
    "drug_route_fr": "Intracardiaque\r\nIntraveineuse",
    "drug_package_quantity": "10 x 10mL LifeShield Syringe",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82818,
    "drug": {
      "current_status": "MARKETED",
      "id": 10902,
      "drug_code": 66824,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254108,
          "ingredient": {
            "id": 2848,
            "ingredient_code": 7509,
            "en_name": "HYDROCORTISONE VALERATE",
            "fr_name": "Valérate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242984",
      "brand_name": "HYDROVAL CREAM 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112513001"
    },
    "created_date": "2019-04-30T16:03:53-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242984",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "decision_reversal": true,
    "en_discontinuation_comments": "HydroVal Cream continues to be available in all sizes",
    "fr_discontinuation_comments": "HydroVal Crème est disponible en tous les formats",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-12-07T21:00:36-05:00",
    "status": "reversed",
    "en_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "en_drug_common_name": "HYDROVAL CREAM 0.2%",
    "fr_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "fr_drug_common_name": "HYDROVAL CREAM 0.2%",
    "en_ingredients": "HYDROCORTISONE VALERATE",
    "fr_ingredients": "Valérate d'hydrocortisone",
    "drug_strength": "0.2%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82821,
    "drug": {
      "current_status": "MARKETED",
      "id": 10904,
      "drug_code": 66825,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254109,
          "ingredient": {
            "id": 2848,
            "ingredient_code": 7509,
            "en_name": "HYDROCORTISONE VALERATE",
            "fr_name": "Valérate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242985",
      "brand_name": "HYDROVAL OINTMENT 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112513001"
    },
    "created_date": "2019-04-30T16:05:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242985",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2019-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "HydroVal OINTMENT 15g is discontinued, other sizes remain available",
    "fr_discontinuation_comments": "Hydroval ONGUENT 15g est discontinué.  D'autres formats restent disponibles.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2019-04-30T16:06:02-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "HYDROVAL OINTMENT 0.2%",
    "en_drug_common_name": "HYDROVAL OINTMENT 0.2%",
    "fr_drug_brand_name": "HYDROVAL OINTMENT 0.2%",
    "fr_drug_common_name": "HYDROVAL OINTMENT 0.2%",
    "en_ingredients": "HYDROCORTISONE VALERATE",
    "fr_ingredients": "Valérate d'hydrocortisone",
    "drug_strength": "0.2%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15 g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82824,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19718,
      "drug_code": 81075,
      "updated_date": "2025-05-15T04:14:37-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8347000,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325357",
      "brand_name": "BUPROPION SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140003"
    },
    "created_date": "2019-04-30T16:33:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325357",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2019-04-30T00:00:00-04:00",
    "actual_end_date": "2019-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-05-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BUPROPION SR",
    "en_drug_common_name": "BUPROPION SR",
    "fr_drug_brand_name": "BUPROPION SR",
    "fr_drug_common_name": "BUPROPION SR",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82835,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3668,
      "drug_code": 19098,
      "updated_date": "2025-05-15T03:45:18-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8302476,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02155990",
      "brand_name": "ADALAT XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81387",
      "number_of_ais": "1",
      "ai_group_no": "0115253005"
    },
    "created_date": "2019-04-30T18:37:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02155990",
    "company_name": "BAYER INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "anticipated_start_date": "2019-07-15T00:00:00-04:00",
    "actual_end_date": "2019-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-02T14:06:00-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ADALAT XL - SRT 60MG",
    "en_drug_common_name": "Nifedipine extended-release tablets Bayer Standard",
    "fr_drug_brand_name": "Adalat XL",
    "fr_drug_common_name": "Nifédipine",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28's and 98's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82837,
    "drug": {
      "current_status": "MARKETED",
      "id": 53515,
      "drug_code": 95539,
      "updated_date": "2025-05-15T02:35:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262664,
          "ingredient": {
            "id": 3520,
            "ingredient_code": 20430,
            "en_name": "DESVENLAFAXINE",
            "fr_name": "Desvenlafaxine (Succinate de desvenlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466988",
      "brand_name": "APO-DESVENLAFAXINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152509001"
    },
    "created_date": "2019-04-30T18:38:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466988",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2019-05-10T00:00:00-04:00",
    "actual_start_date": "2019-04-29T00:00:00-04:00",
    "actual_end_date": "2019-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-13T18:27:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESVENLAFAXINE",
    "en_drug_common_name": "DESVENLAFAXINE",
    "fr_drug_brand_name": "APO - DESVENLAFAXINE",
    "fr_drug_common_name": "DESVENLAFAXINE",
    "en_ingredients": "DESVENLAFAXINE",
    "fr_ingredients": "DESVENLAFAXINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82873,
    "drug": {
      "current_status": "MARKETED",
      "id": 5156,
      "drug_code": 3156,
      "updated_date": "2025-12-03T00:30:21-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250493,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00443832",
      "brand_name": "DEPAKENE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "53218",
      "number_of_ais": "1",
      "ai_group_no": "0112996002"
    },
    "created_date": "2019-04-30T19:02:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00443832",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2019-04-30T00:00:00-04:00",
    "actual_end_date": "2019-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-05-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEPAKENE",
    "en_drug_common_name": "VALPROIC ACID",
    "fr_drug_brand_name": "DEPAKENE",
    "fr_drug_common_name": "VALPROIC ACID",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "50MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "240 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82876,
    "drug": {
      "current_status": "MARKETED",
      "id": 11810,
      "drug_code": 69384,
      "updated_date": "2025-12-03T00:30:49-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254382,
          "ingredient": {
            "id": 2508,
            "ingredient_code": 7485,
            "en_name": "TESTOSTERONE",
            "fr_name": "Testostérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245345",
      "brand_name": "ANDROGEL",
      "brand_name_fr": "",
      "descriptor": "2.5 G GEL PER PACK",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106405004"
    },
    "created_date": "2019-04-30T19:05:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245345",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "G03BA",
    "atc_description": "ANDROGENS",
    "anticipated_start_date": "2019-05-23T00:00:00-04:00",
    "estimated_end_date": "2019-06-03T00:00:00-04:00",
    "actual_end_date": "2019-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-08-15T13:17:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ANDROGEL",
    "en_drug_common_name": "TESTOSTERONE",
    "fr_drug_brand_name": "ANDROGEL",
    "fr_drug_common_name": "TESTOSTERONE",
    "en_ingredients": "TESTOSTERONE",
    "fr_ingredients": "Testostérone",
    "drug_strength": "1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "30s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 82881,
    "drug": {
      "current_status": "MARKETED",
      "id": 23272,
      "drug_code": 85857,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258407,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02373424",
      "brand_name": "MAR-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2019-04-30T20:34:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02373424",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2019-05-01T00:00:00-04:00",
    "actual_start_date": "2019-04-28T00:00:00-04:00",
    "actual_end_date": "2019-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-05-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-LETROZOLE",
    "en_drug_common_name": "Letrozole",
    "fr_drug_brand_name": "MAR-LETROZOLE",
    "fr_drug_common_name": "LETROZOLE",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]